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The immune system presents a unique opportunity for studying development in mammals. White 
blood cells undergo differentiation and proliferation, a never-ending process throughout the life 
of the organism. Hematopoiesis, the development of cells in the immune system, depends upon 
the interaction between many different cell types (some of which comprise less than a tenth of a 
percent of the population), transient regulatory decisions, genomic rearrangement events, cell 
proliferation, and death. To capture these events we employ mass cytometry, a novel technology 
that measures fifty proteins simultaneously in single cells. Mass cytometry results in large 
quantities of high-dimensional data which challenges existing computational techniques. To 
address these challenges, we developed two dimensionality reduction algorithms for analyzing 
mass cytometry and other single-cell data. The first, viSNE, transforms high-dimensional data 
into an intuitive two-dimensional map, making it accessible to visual exploration. The second 
algorithm, Wanderlust, receives as input a static snapshot (where cells occupy different stages of 
their development) and constructs their developmental ordering: the developmental trajectory. 
viSNE maps healthy bone marrow into a canonical shape that separates cell subtypes. In 
leukemia, however, the shape is malformed: the maps of cancer samples are distinct from the 




surface phenotype expression in cancer, traverses the progression from diagnosis to relapse, and 
identifies a rare leukemia population in minimal residual disease settings. 
Wanderlust was applied to healthy B lineage cells, where the trajectory follows known marker 
expression trends and genetic recombination events. Using the Wanderlust trajectory we 
identified CD24 as an early marker of B cell development. The trajectory captures the 
coordination between several regulatory mechanisms (surface marker expression, signaling, 
proliferation and apoptosis) during crucial development checkpoints. 
As new technologies raise the number of simultaneously measured parameters in each cell to the 
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Chapter 1 Introduction 
1.1 Single-cell analysis of the immune system 
The immune system is one of the organism’s central lines of defense against pathogens [1]. It is a 
complex system, composed of many different cell subtypes, most of which belong to one of two 
major lineages [2]: the myeloid lineage (that includes monocytes, macrophages, erythrocytes and 
others) and the lymphoid lineage (T cells, B cells and NK cells). Each such subset can be further 
divided into multiple high-specialized cell subtypes. All immune system cells share a common 
ancestor, the hematopoietic stem cell (HSC) [2]. The HSC gives rise to different progenitors that 
in turn develop into the final, differentiated cells. 
Both the healthy and the diseased immune system depend upon the interaction between many 
different cell types (some of which comprise less than a tenth of a percent of the population), 
transient regulatory decisions, genomic rearrangement, cell proliferation, and death. Due to this 
high level of heterogeneity, single-cell methods are an ideal choice for exploring the immune 
system. Flow cytometry has become a technology of choice for cellular analysis in the immune 
system. It has paved the way to understanding many different cellular processes in immunology 
and in other fields, such as profiling phosphor-protein networks in cancer cells [3], elucidating 
causal influences in protein-signaling networks [4], identifying the hierarchy between three 
different types of stem cells in human [5], and exploring the role of stem cells in healthy systems 
[6] and in cancer [7]. 
In the context of the immune system, a typical flow cytometry experiment will assay four to 





form of a protein (such as phosphorylated state). They belong to one of several categories. 
Surface markers, which reside on the cell’s membrane, are mostly receptors (though they fill 
other functions as well, such as enzymes in the case of CD45). They are most often used for 
classification of cell type. Signaling markers are present in the cell’s cytoplasm and transduce 
signals from outside and within the cell. They allow us to assay the cell’s current activity and its 
regulation. Additional markers might also be used, including cell cycle markers (Ki67 and cParp 
in this work), genomic recombination markers (TdT and Rag1/2) or transcription factors. 
From a computational point of view, the output of the flow cytometer is a matrix with a column 
for each marker and a row for each cell. Before actual analysis can commence, several pre-
processing steps need to be done. First, the instrument accumulates debris, such as cell 
fragments, that needs to be filtered out (gated), usually based on their size or lack of DNA. Cell 
types which are not relevant to the current research should also be removed- for example, T cells 
in a B-cell experiment. Next, the measurements of each marker need to be compensated due to 
fluorescence spectral overlap, a phenomenon where the light spectrum of one fluorochrome 
overlaps another. Finally, during the analysis itself, antibody “stickiness” should be considered: 
while antibodies have the highest affinity to their target, they also bind to other molecules 
(including the cell’s membrane), and form a source of noise that needs to be acknowledged. 
Improvements in optics and hardware and the discovery of new fluorochromes have steadily 
increased the number of concurrent parameters that can be measured in each cell [8] and recent 
work has reached 15-color experiments [9]. However, due to fluorescence spectral overlap, 
compensation becomes more challenging as the number of colors increases, resulting in difficult 





number of parameters that flow cytometry can measure. A different technology is required in 
order to capture the full complexity of the immune system. 
Mass cytometry [8, 12, 13] offers a variation on flow cytometry by attaching lanthanide isotopes 
to the antibodies targeting the proteins of interest (instead of fluorochromes as in flow 
cytometry). The isotope levels in each cell are measured using an atomic mass spectrometer. 
Since there is no spectral overlap, no compensation is required. The method can currently 
measure approximately 50 parameters per cell, with a theoretical limit of 100 parameters per cell 
[14, 15]. Mass cytometry is joined by other recent technological advances that have enabled the 
study of a large number of parameters in single cells. For example, high-resolution microscopy 
[16, 17] and single-cell RNA quantification [18-21] allow analysis of 100 parameters in 
hundreds and soon thousands of individual cells. These innovations promise to transform the 
way we research, study and think about development, differentiation, and disease [8, 13, 22].  
Mass cytometry and similar groundbreaking single-cell technologies raise several computational 
challenges. One, merely visualizing such high-dimensional data (millions of cells over a hundred 
dimensions) in an intuitive, accessible manner is daunting. Innovative methods will be required 
to give us an initial window to understanding the complexities therein. Two, the regulatory 
pathways in biological systems are complex and involve feedback and crosstalk [23, 24]. 
Therefore, analysis cannot assume simple pairwise or linear relationships, but should adopt a 
systematic approach and integrate information from all of the parameters available. Three, 
single-cell technologies often aim to measure miniscule amounts of each target protein, leading 
to high noise levels which should be acknowledged and addressed. The combination of these 
issues calls for the development of novel computational approaches for the analysis of high-





1.2 Dimensionality reduction 
In the context of the current work, the challenge of analyzing high-dimensional single-cell data is 
answered using dimensionality reduction [25]. As its name implies, dimensionality reduction is a 
class of algorithms that transform high-dimensional data into a compact lower-dimensional 
representation. The number of dimensions in the reduced representation depends on its purpose. 
When the goal is to reduce the memory or computational requirements for further analysis the 
number of dimensions will be dictated by the computational complexity of that analysis or the 
size of available memory [26-28]. Oftentimes, however, the purpose of dimensionality reduction 
is to enable exploration and classification of the data by creating effective visualization [29]. In 
such cases, the number of dimensions in the reduced representation is set to two or three, 
facilitating its visualization and making it accessible to human researchers. 
Dimensionality reduction is defined as follows: given a data set X, (represented as a matrix of 
size N x D, denoting N observations in D dimensions), we are looking for a projection of X into a 
lower-dimensional matrix Y of size N x d, where d << D. The projection should maintain the 
geometry of X. The minimal d that is required to preserve the geometry of X is called the 
intrinsic dimensionality of the data. 
This definition portrays the two central challenges to dimensionality reduction. One, the 
geometry of X is often unknown or ill-defined. Therefore, it is rarely possible to provide an 
accurate, quantitative metric that describes the similarity between the geometries of X and Y. The 
initial assumption of any dimensionality reduction algorithm is the definition of the geometry to 
be preserved. Two, we do not know the value of d, the intrinsic dimensionality of X. While 





might mismatch or contradict the algorithm’s geometry assumption, and the intrinsic 
dimensionality might be higher than afforded by our goal (for example, no matter the value of d, 
we cannot visualize more than three dimensions). A robust dimensionality reduction algorithm 
should address these concerns. 
Principal component analysis (PCA) [29] and factor analysis (FA) [33] are two leading and well-
studied methods of dimensionality reduction. Briefly, PCA is a linear transformation of the data 
into the principal eigenvectors (called components) of the covariance matrix of the zero-mean 
centered X. The components are orthogonal and maximize the amount of variance in the data. 
The first component has the largest variance and therefore accounts for the most information in 
the data. The variance decreases as the components increase (second, third, etc.). FA, a similar 
method, searches for latent variables, called factors. The data is modeled as a combination of the 
factors and is fit using linear regression. The factors are then explained as real-world phenomena 
that give rise to the data. While PCA and FA are related, they follow opposite conceptual 
approaches: PCA extracts the component while FA estimates the factors. 
PCA has been successfully applied in many biological contexts, for example: de-convoluting in 
vivo signaling data [34], providing a visual validation for a gene-based noise modelling [35], and 
in previous work relating to detecting a small subset of the B-lineage trajectory [12]. Despite its 
success, at the basis of PCA (and FA) lies the assumption that the relationship between variables 
in the data is linear. However, nonlinearity is abundant across many real-life systems, including 
in fields as diverse as ecology [36], machine vision [37], engineering [38], and biology [4, 12, 
39, 40]. In all of these, nonlinearity is the norm rather than the exception. While PCA and FA 
might offer rough outlines of the data’s true structure, more often than not they will lead to 





challenge of quantifying the accuracy of the resulting model: initial observation might suggest 
that a linear approximation is correct, missing more subtle nuances of the data. 
Recent years have seen a resurgence of nonlinear dimensionality reduction algorithms. Broadly, 
these can be classified into one of two categories: projective methods and manifold modeling 
[41]. Projective methods aim to preserve global properties of the data. They define a metric that 
considers all of the data points and optimize that metric in the low-dimensional representation. 
Manifold modeling, on the other hand, is based on preserving local properties of the data. A 
manifold is a topological space that resembles Euclidean space in the close vicinity of each point 
[42]. Manifold modeling methods approximate the manifold by examining a small neighborhood 
around each data point and match the neighborhood’s structure between the low- and high-
dimensional representations. Another important classification that crosses both categories is 
spectral methods [43], which derive the low-dimensional matrix from the eigenvectors of a 
matrix constructed from X. Based on these definitions, PCA is spectral while FA is not, and both 
methods are linear and projective. 
Isomap is a characteristic projective method [44]. Isomap’s goal is to preserve the intrinsic 
geometry of the data, based on the definition of the geodesic distance: the distance between a 
pair of points across the manifold. The algorithm has three steps. First, the data is transformed 
into a nearest-neighbors graph, where a nearest-neighbor is defined either as a point in a given 
radius, or one of the k nearest neighbors. Then, Isomap estimates the geodesic distance between 
each pair of points as the shortest-path distance across the graph. Finally, Isomap applies 
multidimensional scaling [45], an extension of PCA to non-Euclidean distances, to the matrix of 
graph distances. Multidimensional scaling preserves the geodesic distances in the low-





scaling, it is computationally efficient, has a global optimum, and is guaranteed to asymptotically 
converge, three favorable algorithmic characteristics. 
Two other popular projective methods are maximum variance unfolding (MVU) [46] and Kernel 
PCA [47]. MVU extends Isomap by trying to maximize the Euclidean distance between data 
points while preserving the geodesic distances, with the goal of unfolding the manifold [48]. This 
additional constraint necessitates optimization through semidefinite programming, increasing run 
time and losing the asymptotic convergence guarantee. Kernel PCA extends PCA into a 
nonlinear method through the application of the so-called kernel trick [49]. A kernel function 
maps the data space into a higher-dimensional feature space and PCA is run over the feature 
space. The method is fast and guaranteed to converge. However, kernel function selection is 
critical and there are no computational methods for choosing the correct one for the data at hand. 
Locally linear embedding (LLE) [50] is one of the earliest and best-studied manifold modeling 
methods. Following a conceptual approach opposite to that of Isomap, LLE concerns itself only 
with optimizing tight, local neighborhoods. As with the previous algorithms, LLE begins by 
finding the nearest neighbors for each data point. Next, for each point, it computes a series of 
weights that best reconstruct the point from its neighbors; appropriately, these are referred to as 
reconstruction weights. This calculation is formed as a least-squares pro-Blem. The combination 
of all of the reconstruction weights forms a sparse matrix W. On its last step, LLE returns the 
low-dimensional representation that best preserves these weights by solving the spectral pro-
Blem of finding the d smallest eigenvectors of W. The embedding is nonlinear since the matrix is 
based solely on local neighborhoods. Thanks to W’s sparsity, LLE is computationally fast and 





Two notable additional manifold modeling methods are Hessian eigenmaps [51] and stochastic 
neighbors embedding (SNE) [52]. Hessian eigenmaps waives an assumption shared by both 
Isomap and LLE, namely, that the high-dimensional space is convex. When embedding the data 
in the low-dimensional space, the algorithm first minimizes the local curvature of the high-
dimensional space using a Hessian estimator, which is calculated using PCA. The estimators 
form a matrix H, and its d smallest eigenvectors are the low-dimensional representation. Hessian 
eigenmaps is also referred to as Hessien LLE due to similarity of this final spectral step to the 
aforementioned algorithm. SNE replaces LLE’s “hard” neighborhoods with a “soft”, pro-
Babilistic neighborhood definition. The Kullback-Leibler divergence between the set of pro-
Babilities in the high- and low-dimensional spaces is minimized using gradient descent. SNE 
forms the basis of t-SNE, which in turn is the heart of viSNE, one of the novel methods defined 
in this work, and is therefore described in detail later. 
1.3 viSNE and Wanderlust 
Here we introduce two novel dimensionality reduction methods for exploring single-cell data, 
and our findings from applying these methods to questions about the structure, shape and 
development of the immune system. 
In chapter 2 we discuss viSNE, a dimensionality reduction algorithm that maps high-dimensional 
data into two dimensions. The viSNE map is reminiscent of a scatter plot, a central tool in 
immunology, and therefore forms a familiar visual. However, it preserves pairwise relationships 
from the high-dimensional space and therefore encapsulates information that would not be 
accessible otherwise. In the immune system, for example, the viSNE map faithfully captures the 





identifies the progression of cancer from diagnosis to relapse, and detects a tiny cancer 
population in an otherwise healthy sample. The viSNE map validates expected notions about the 
system while serving as a hypothesis-generation tool, revealing unfamiliar behaviors that can be 
further researched. 
In chapter 3 we present Wanderlust, a graph-based trajectory detection algorithm. Wanderlust 
receives a snapshot of a developing system and outputs its underlying trajectory: the temporal 
ordering of the cells. The trajectory detection is done de novo and requires no prior knowledge of 
the system other than a single starting cell. The trajectory serves as scaffolding: we preserve the 
resolution of the single-cells, but instead of examining each cell, we instead explore the ordering 
of developmental events.  This allows us to move from constituent cells underlying development, 
to ordering the developmental events themselves. When applied to mass cytometry data of B 
lineage cells, the Wanderlust trajectory follows known trends of B cell development. We 
validated the ordering of cells identified by the algorithm by confirming that the DNA 
rearrangement status of immunoglobulin across the trajectory follows the expected chronology. 
Through the trajectory we show how different regulatory mechanisms are coordinated in 
developmental checkpoints. The bone marrow contains cells from all differentiation steps, 
allowing Wanderlust to extract these results from a single time point. Applications of the 
algorithm can potentially extend beyond the immune system to any system where acquisition of 
time-series data is difficult or impossible or when the developmental process is only partly 
known. 
The abundance of novel single-cell technologies is an invaluable addition to our arsenal of 
research methods. Biological systems involve high-order relationships, heterogeneity and 





we are examining. We are certain that viSNE and Wanderlust, two powerful, complementary 
methods for the exploration and analysis of high-dimensional data, will be imperative in utilizing 
single-cell technologies to the fullest. 
The rest of this work is organized as follows. Chapter 2 discusses the viSNE algorithm, its 
implementation, the viSNE maps of healthy and cancer bone marrow samples, and the 
algorithm’s application in minimal residual disease settings. Chapter 3 introduces the intuition 
behind Wanderlust and the technical details of the algorithm, and showcases its robustness when 
applied to synthetic data. Chapter 4 revolves around application of Wanderlust to the 
development of B-lineage cells in the healthy immune system. Chapter 5 presents the broader 
implications of the algorithms presented for current biological experimentation and for the future 






Chapter 2 viSNE enables visualization of high-
dimensional single-cell data and reveals 
phenotypic heterogeneity of leukemia  
The following text is a reprint of Amir et al. [53]. 
2.1 Introduction 
Emerging single-cell technologies have revealed an extensive degree of heterogeneity between 
and within tissues [8]. Analysis of single-cell data has shed light on many different cellular 
processes [3-7, 54] and recent technological advances have enabled the study of a large number 
of parameters in single cells at unparalleled resolution. For example, mass cytometry [14] can 
measure up to 45 parameters simultaneously in tens of thousands of individual cells. High-
resolution microscopy [16, 17] and single-cell RNA quantification [18-21] allow analysis of 100 
parameters in dozens and soon hundreds of individual cells. These innovations promise to 
transform the way we think about development, differentiation, and disease [8, 13, 22]. 
However, it is difficult to visualize such high numbers of dimensions in a meaningful manner. 
Single-cell data is often examined in two dimensions at a time in the form of a scatter plot [55]. 
Yet, as the number of parameters increases, the number of pairs becomes overwhelming. A 
typical mass cytometry dataset allows several hundred pairwise combinations. In addition, a 
pairwise viewpoint could miss biologically meaningful multivariate relationships that cannot be 
discerned in two dimensions. Several computational tools, such as SPADE [56], have been 





and examine the average of each cluster, resulting in the loss of single-cell resolution of the data. 
Principal component analysis (PCA) [29], another computational tool, has been applied to mass 
cytometry datasets [12] and can be used to project data into two dimensions while maintaining 
single-cell resolution. However, PCA is a linear transformation that cannot faithfully capture the 
nonlinear relationships that are a hallmark of many single-cell datasets. Therefore, we need new 
tools to visualize and interpret high-dimensional single-cell data such as those produced by mass 
cytometry. An ideal tool would enable visualization at single-cell resolution, preserve the 
geometry and nonlinearity of the data, represent both abundant and rare populations, and provide 
a robust, interpretable view of the data. 
We developed viSNE for this purpose. viSNE allows visualization of high-dimensional single-
cell data and is based on the t-Distributed Stochastic Neighbor Embedding (t-SNE) algorithm 
[12]. viSNE finds the two dimensional representation of single-cell data that best preserves their 
local and global geometry. The resulting viSNE map provides a visual representation of the 
single-cell data that is similar to a biaxial plot, but the positions of cells reflect their proximity in 
high-dimensional rather than two dimensional space. We utilize color as a third dimension to 
interactively visualize features of these cells. Here we apply viSNE to interpret mass cytometry 
data derived from healthy and leukemic human bone marrow.  
2.2 Results 
2.2.1 Preserving high-dimensional relationships in single-cell data 
In viSNE, each cell is represented as a point in high-dimensional space. Each dimension is one 
parameter (i.e, the expression level of one protein). An optimization algorithm searches for a 





pairwise distances between the points are best conserved between the high- and low-dimensional 
spaces (see Materials and Methods). The resulting low-dimensional projection, which we call the 
viSNE map, is visualized as a scatter plot, where a cell’s location in the plot represents 
information from all of the original dimensions.  
We also developed cyt, an interactive tool for visualization of viSNE maps. cyt has multiple 
features, including plotting the maps, coloring cells by marker expression, sample or subtype, 
and gating. Figure 2-1A demonstrates how viSNE works on a synthetic example; the 
optimization algorithm identifies the global structure of the data (a 1D line, along with its 
curvature, embedded in 3D space) and the local structure (pairwise distances between points 






Figure 2-1. viSNE map of healthy human bone marrow. 
(a) In a synthetic toy example, viSNE projects a one-dimensional curve embedded in three dimensions (left) 
onto two dimensions (right). The color gradient shows that points that are in close proximity in three 
dimensions remain in close proximity in two dimensions. (b) Application of viSNE to a healthy human bone 
marrow sample, stained with 13 markers and measured with mass cytometry [12] automatically separates cells 
into spatially distinct subsets based on the combination of markers that they express. Each point in the viSNE 
map represents an individual cell and its color represents its immune cell subset as designated by independent 
expert manual gating (manual gates are defined at the bottom). Gray points were not classified by manual 
gating. The axes are in arbitrary units. (c) Biaxial plots represent the same data shown in panel b, and show the 
gates drawn manually by expert operators. The colors of the squares match the colors in panel b. The actual 
manual gating used here is more complex and uses a series of biaxial plots to gate each population [12]. Note, 
that unlike in panel b, no single biaxial plot spatially separates all subsets. (d) The same viSNE map shown in 
panel b is colored according to intensity of CD11b expression. Many of the cells within the dotted line gate 





2.2.2 viSNE map of healthy human bone marrow  
First, we evaluated viSNE’s ability to map the well-characterized system of human bone marrow 
hematopoiesis [2]. We analyzed previously generated data of healthy human bone marrow 
(Marrow 1) stained with elemental isotope-conjugated antibodies specific for 13 surface markers 
[12]. When applied to this dataset, viSNE generated a map that clearly separated different cell 
subsets in space (Figure 2-1b). To validate and label the map, we used an independently derived 
classification of the cells based on expert manual gating of a series of biaxial plots (Figure 2-1c; 
see Materials and Methods). Although viSNE was not provided with this classification or with 
any knowledge of immune subsets, it successfully grouped cells of the same subset together and 





 T cells, mature and immature B cells, mature and immature monocytes and natural killer 
(NK) cells. Notably, NK cells formed a distinct subset even though CD56, the canonical marker 
associated with this lineage, was not included in the antibody staining panel. 
To further compare the expert manual gating and the viSNE map, we used the cyt feature to gate 
subsets directly from the viSNE map (Figure 2-2a). In all cases, the viSNE gate included cells 
that were not classified by the expert manually gated biaxial plots; these cells are labeled in grey 
in the viSNE map. Examination of the marker expression of these cells reveals that they are 
typically just beyond the threshold of one marker, but the viSNE classification is strongly 
supported based on the expression of all other markers. For example, in Figure 2-1d, wherein 
cells are colored for CD11b marker expression, the cells in the gated region express the 
canonical monocyte marker CD33 (Figure 2-2b). However, only 47% of these cells were 
classified as monocytes by the manual gating (Figure 2-1b). In addition, the marker intensity 





manually set monocyte gate (Figure 2-2c) are similar, supporting the notion that the cells gated 
in the viSNE map are indeed CD11b- monocytes. 
 
Figure 2-2. A viSNE map can classify cells that were labeled incorrectly by manual gating. 
(a) viSNE map is identical to Figure 2-1b. Each of the cell subtypes is surrounded by a gate corresponding to 
that subtype’s color as designated by manual gating. Grey points inside the viSNE map gate were not classified 
by manual gating, although further examination reveals that they belong to the relevant subtype. In addition, 
there are four regions that do not conform to known subtypes. Region A has cells positive for CD45 only, we 
suspect these are missing a marker needed to classify them. Region B includes doublets: pairs of cells that 
were read together by the machine as if a single cell, and are therefore positive for suspect marker 
combinations (for example, CD19+ CD11b+). The cells in Region C are negative for all channels and are pro-
Bably debris. Region D has cells positive for CD45 and CD3 only, these might be NKT cells whose canonical 
marker is missing. (b) The same map as in A, coded by CD33 (myeloid marker) expression. The monocyte cell 
population is clearly visible to the top right. (c) Marker expression level densities for the entire population 
(grey), the manually gated CD11b- monocyte cells (black) and the viSNE gated CD11b- monocytes cells 
(pink, as shown in panel A). The two CD11b- monocyte populations have almost identical marker 





CD3 expression is significantly lower than that on bona fide CD3+ cells. Rather than exclude these cells based 
on a hard threshold on a single marker, viSNE groups the cells together based on their tight similarity in all 
other markers. Taken together these data support viSNE’s identification of CD11b- monocytes. (d) Gating 
using the viSNE map is typically more accurate than manual gating, since 2D views and hard thresholds can be 
misleading. There are a number of cells labeled as CD20+ B-cells by viSNE (dark green outline in A) and 
labeled NK cells based on biaxial gating (orange dots within the B-cell region). These cells just miss the hard 
CD19 threshold in one of the gates (black dashed line) and therefore their CD20 level is never examined 
during the gating (the presented biaxial plot is not part of the gating scheme used). Their high CD20 levels and 
borderline CD19 levels support their labeling as B-cells, rather than NK-cells. Their CD38 levels further 
support their B-cell label. 
Traditional gating relies on hard thresholds to classify cells into subsets. Thus cells whose 
marker values are slightly below or above the threshold might not be classified correctly, or 
classified at all (Figure 2-2d). When dealing with the hematopoietic continuum, this may result 
in the inability to accurately capture transitional cell types. For example, using cyt to color cells 
based on marker intensity revealed that viSNE organized monocytes based on a gradient or 
smooth increase in expression of CD11b, a marker of monocyte maturity (Figure 2-1d). This 
finding highlights the continuous and gradual nature of CD11b expression during monocyte 
maturation and better represents the continuum of normal differentiation [59]. viSNE takes into 
account all phenotypic markers concurrently instead of relying on hard thresholds and, as a 
result, classifies more cells and captures a more accurate view of the variability within each 
subset when compared to biaxial gating. The single cell resolution of the viSNE map provides 
fine detail of each subset, going beyond clustering and enabling investigation of the variation, 
structure and transitions within each subset. 
2.2.3 Robust subset classification even without canonical markers 
We performed a number of analyses to evaluate the robustness of viSNE. The viSNE map in 
Figure 2-1b includes 10,000 cells that were subsampled from the complete data set of Marrow1. 
We independently subsampled multiple subsets of the data and ran viSNE on each. Reassuringly, 





between subsets. Thus the viSNE map consistently and reliably represents real structure in the 
data.  
To test viSNE’s reliance on specific markers for classification of immune cell subsets, we 
generated multiple viSNE maps but excluded some of the markers when generating each map. 
The viSNE map remained consistent in terms of spatial separation of subsets even after removal 
of any single marker (Figure 2-3a). Remarkably, even after excluding the canonical markers of B 
cells, T cells and myeloid cells (CD19/CD20, CD3 and CD33, respectively), the viSNE map 
remained consistent with the map constructed using all thirteen markers (Figure 2-3a). These 
findings imply that non-canonical markers, when analyzed together, contain the information 
needed to separate distinct immune cell subsets. This speaks to a previously unappreciated level 
of organization where specialized immune subtypes have tightly coordinated surface marker 
expression beyond their canonical identifiers. The different subtypes reside in distinct well-






Figure 2-3. viSNE is robust, consistent, does not require canonical markers. 
(a) The left map is the same as in Figure 2-1b, and was generated by considering all 13 markers. Middle: 
viSNE map of the same cells, projected after removing CD33. Right: viSNE map of same cells, projected after 
removing CD33, CD3, CD19 and CD20. Despite removing four canonical markers, viSNE separates most 
major subtypes using the remaining nine channels. (b) Bone marrow samples from three healthy donors 
(Marrow2-4) were mapped using viSNE. Each point represents a single cell, and different colors represent 
different samples. (c) The map is the same map as in panel b, but is color coded by cell subset as identified by 
analyzing gradients of expression of individual markers. Subsets are indicated below the map. (D) Bone 
marrow samples from two healthy donors (Marrow5-6) and two pediatric B-cell ALL patients (ALL A-B) 
were mapped using viSNE. Samples are color-coded as indicated in key. 
2.2.4 Consistent and reproducible healthy bone marrow map 
Having demonstrated viSNE’s robustness when applied to a single healthy bone marrow sample, 





Three healthy bone marrow samples (Marrow2-4) were assayed by mass cytometry using a panel 
of 31 phenotypic surface markers. The resulting viSNE map grouped cells into distinct 
subpopulations, and cells from all three individuals overlapped within each subpopulation 
(Figure 2-3b). We used the Jenson-Shannon (JS) divergence to quantify the similarity between 
the viSNE maps of the three individuals (see Materials and Methods). The JS divergence 
between each pair of healthy individuals was 0.04, confirming that there is almost no divergence 
between the viSNE maps of healthy samples. Using cyt to visualize expression gradients of 
individual markers, we gated specific immune cell subsets in viSNE maps (Figure 2-3c).  
To further evaluate the robustness of viSNE’s map of healthy bone marrow, we applied viSNE to 
an additional bone marrow sample collected using conventional fluorescence-based flow 
cytometry. The resulting viSNE map is similar to the map generated by mass cytometry (Figure 
2-4), demonstrating not only consistency in the map between healthy samples, but also that 
viSNE is well-suited for the analysis of fluorescence-based cytometry data. The cellular subtypes 
comprising the human immune system are reproducibly represented by viSNE and the fidelity of 
this structure is maintained across multiple cytometry platforms, marker panels, and most 






Figure 2-4. viSNE can be used for the analysis of flow cytometry data. 
viSNE map of flow cytometry data of healthy bone marrow. The flow cytometry panel includes eight markers 
(CD45, CD45RA, CD3, CD4, CD8, CD33, CD20, CD7) and therefore identifies fewer subsets. 
2.2.5 Deformed shapes of leukemic bone marrow maps 
Encouraged by the consistency and robustness of viSNE maps of healthy bone marrow samples, 
we used viSNE to analyze leukemic bone marrow. We stained two bone marrow samples 
donated from healthy individuals and two from pediatric acute B-cell lymphoblastic leukemia 
(B-cell ALL) patients with a panel of 29 antibodies optimized for the analysis of B-cell ALL 





addition of anti-CD61 and anti-CD117 to the panel, whereas the CD4 and CD8 T cell 






Figure Section Dataset 
Cells 
subsampled Markers used 
1 B/D Marrow1 
10,000 cells 
from Marrow1 
CD11b, CD123, CD19, CD20, CD3, CD33, CD34, CD38, 
CD4, CD45, CD45RA, CD8, CD90 
2 
A left 
The exact same cells as 
Figure 1B/D 
CD11b, CD123, CD19, CD20, CD3, CD33, CD34, CD38, 
CD4, CD45, CD45RA, CD8, CD90 
A 
middle 
CD11b, CD123, CD19, CD20, CD3, CD34, CD38, CD4, 
CD45, CD45RA, CD8, CD90 
A right 
CD11b, CD123, CD34, CD38, CD4, CD45, CD45RA, CD8, 
CD90 
B/C Marrow2 Combination 
of 4,000 cells 
from each of 
these samples 
CD10, CD117, CD11a, CD123, CD127, CD179b, CD19, 
CD2, CD20, CD22, CD235, CD3, CD33, CD34, CD38, 
CD43, CD45, CD45RA, CD45RO, CD47, CD49d, CD5, 
CD61, CD7, CD79b, CXCR4, HLADR, IgD, IgM 
Marrow3 
Marrow4 
D Marrow5 Combination 
of 2,500 cells 
from each of 
these samples 
CD10, CD117, CD11b, CD127, CD133, CD179a, 
CD179b, CD19, CD20, CD22, CD24, CD3, CD33, CD34, 
CD38, CD43, CD45, CD45RA, CD47, CD49d, CD61, CD7, 








from ALL A 
CD10, CD117, CD11b, CD127, CD133, CD179a, 
CD179b, CD19, CD20, CD22, CD24, CD3, CD33, CD34, 
CD38, CD43, CD45, CD45RA, CD47, CD49d, CD61, CD7, 
CD72, CD79b, CXCR4, Flt3, HLA-DR, IgM, pre-BCR ALL B 
10,000 cells 




from AML A 
CD114, CD117, CD123, CD133, CD14, CD15, CD16, 
CD19, CD2, CD20, CD22, CD3, CD33, CD34, CD38, 
CD44, CD45, CD45RA, CD47, CD49d, CD5, CD56, CD64, 




from AML B 
C 
The exact same cells as 






of 5,000 cells 






The exact same cells as 
Figure 4, Relapse 
CD114, CD117, CD123, CD133, CD14, CD15, CD16, 
CD19, CD2, CD20, CD22, CD3, CD33, CD34, CD38, 
CD44, CD45, CD45RA, CD47, CD49d, CD5, CD56, CD64, 
CD7, CD79b, CD90, CXCR4, Flt3, HLADR,  
6 
  
MRD 10,000 cells, 
biased 
subsampling 
from each of 
these samples 
(see text) 
CD10, CD15, CD20, CD3, CD34, CD38, CD45, CD7 
Control 
 
Table 2-1. Experiment details, per figure. 
Figure and section refers to the location of the figure in the text. In Dataset, Marrow stands for healthy bone 





experiment. “Cells subsampled” is the number of cells subsampled from the whole dataset. “Markers used” is 
the list of surface markers measured in the dataset. 
The maps of the two healthy bone marrow samples (Marrow5-6) overlap (JS divergence 0.04) 
(Figure 2-3d). In contrast, the two ALL samples occupy a completely separate region within the 
viSNE map (JS divergence 0.45), and each forms a distinct population separate from the other 
ALL sample (JS divergence 0.42). Some cells from the ALL samples (~5%) overlap with cells 
from the healthy samples. Inspection of these cells revealed marker combinations that 
correspond to healthy immune cells, supporting their placement with the other healthy cells.  
When we applied viSNE separately to each ALL sample, each sample mapped into a large 
deformed shape (Figure 2-5a) and several smaller shapes; the latter corresponded to healthy 
immune cell populations, indicating that the malignant cells were related to each other but 
sufficiently distinct from healthy cells. We also applied viSNE to two acute myeloid leukemia 
(AML) patient samples. The viSNE maps of these AML samples also displayed a single large 
deformed shape (Figure 2-5b), in contrast to the separated and distinct subpopulations of healthy 
samples. We noted a considerable population structure within each cancer, as discerned by 
multiple peaks and saddle points in the contour map. Moreover, each cancer sample formed a 
unique viSNE map, in which healthy subpopulations were consistently separated from the 






Figure 2-5. Cancer samples form contiguous but heterogeneous shapes. 
(a, b) Contour plots of the viSNE maps of two different ALL (a) and AML (b) samples. The contours represent 
cell density in each region of the map. Small gated populations represent indicated healthy immune subtypes as 
revealed by examination of their marker expression. Since the structure of each tumor dramatically changes 
between samples, viSNE places the healthy regions in different locations in each map (as each healthy subtype 
is positioned as close as possible to the most similar cancer cells). (c) viSNE map of a diagnosis bone marrow 
sample from AML patient 1. Cells are colored according to intensity of expression of the indicated markers. 
CD20 helps identify the healthy B cell subpopulation. 
2.2.6 viSNE can explore cancer heterogeneity 
While healthy samples can be studied by biaxial gating based on known surface phenotypes of 
individual immune cell subsets, exploring cancer heterogeneity in high dimensions can be a 
daunting task as cancer samples frequently display abnormal combinations of surface markers 





practice, hematopoietic malignancies are analyzed using at most four to eight markers 
simultaneously. Hematopoietic malignancy immunophenotyping results have typically been 
displayed using biaxial plots focused on key markers. However, by combining mass cytometry 
with viSNE, we are able to visualize cancer at single cell resolution in a single map that takes 
into account ~30 markers; this sort of analysis can reveal additional structure, abnormal marker 
combinations and subpopulations.  
We used viSNE to comprehensively characterize a diagnostic AML bone marrow sample. 
Although the overall viSNE map shape of cancer is deformed compared to that of healthy bone 
marrow, some markers (e.g. CD33, CD34 and HLA-DR) show gradients of expression whereas 
others (e.g. CD79b) show clustered expression (Figure 2-5c).Within the subpopulation of cells 
that highly express CD34 (a marker of stem/progenitor cells) is a gradient of expression of CD33 
(a marker of monocytes; Figure 2-5c). This marker combination suggests a derailed development 
program in cancer, because during normal healthy immune cell development, as monocytes 
mature, expression of CD34 (a marker of immaturity) decreases. Perhaps in this cancer, 
oncogene activity promoted a progenitor-like CD34
+
 state, but the cells continued to differentiate 
aberrantly as indicated by the induction of CD33 expression. The single cell resolution of viSNE 
highlights cancer as a continuum of heterogeneous phenotype states, demarcated by gradients of 
marker expression rather than distinct subpopulations.  
2.2.7 Comparing diagnosis and relapse samples 
Because the viSNE map might reflect aspects of cancer progression, we used viSNE to analyze 
two samples from a single AML patient: one sample was taken before chemotherapy and the 
other was taken after disease relapse. The map was generated using a merged dataset composed 





and relapse samples (Figure 2-6a). viSNE reveals phenotypes unique to the diagnosis sample, 
which are presumably eliminated by chemotherapy, as well as phenotypes that arise only at 
relapse. Notably, the viSNE map identifies a region of phenotypes occupied by both samples, but 
that is considerably rarer at diagnosis. This may suggest enrichment of a rare drug-resistant clone 
that maintained a consistent phenotype from diagnosis to relapse. We also note populations of 
healthy cells that overlap in the diagnosis and relapse sample viSNE maps; these provide an 
internal technical control for the similarity of staining between samples. Regarding specific 
markers, FLT3 expression is pervasive in the diagnosis sample, but diminished in the relapse 
sample. Genetic analysis of the diagnosis sample revealed an internal-tandem duplication of 
FLT3, a common mutation in AML [60], suggesting relapse derived from a clone lacking this 
mutation (FLT3 genetic status at relapse was unavailable). The clone that reemerged at relapse 
had an altogether different and more immature phenotype, with cells expressing both high CD34 
and CD33 throughout a large fraction of the sample (Figure 2-6b). The relapse sample was 
highly heterogeneous, as distinct regions expressed different markers from the myeloid lineage 







Figure 2-6. viSNE reveals the progression of cancer from diagnosis to relapse. 
(a) Contour plots of the viSNE maps of diagnosis and relapse AML samples in patient AML B. The contours 
represent cell density in each region in the map. The map is the same in each sample. Each point represents a 
cell from the diagnosis (top, purple) or relapse (bottom, red) sample. (b) Cells from both diagnosis and relapse 
samples are shown in each map, and the map is the same as in (a). Cells are colored according to intensity of 
expression of the indicated markers, enabling the comparison of expression patterns before and after relapse. 
For example, Flt3 is expressed primarily in the diagnosis sample. CD34 emerges in the relapse sample, as do 
CD64 and CD7. There is a CD33 gradient in both samples. The overlapping region has cells that express high 
levels of CD49d. 
To allow further dissection of the heterogeneity of the AML sample using experimental tools 
such as DNA and RNA sequencing, we used the viSNE map to devise a gating scheme that is 
compatible with fluorescence-activated cell sorting (FACS). We divided the AML sample into 
subpopulations based on expression of CD33, CD34, CD7 and CD64. We classified each marker 
as “on” (positive) or “off” (negative) according to a threshold that was chosen using the map 





population, and applied the CD64 and CD7 gates to it (Figure 2-7b). When examining the 
intersection of all eight groups (two for each marker), we identified six distinct subpopulations 





would be to physically separate the relapse sample into these subpopulations using FACS and 







Figure 2-7. A gating scheme for fluorescence-activated cell sorting (FACS) of an AML relapse sample in 
patient B based on the viSNE map. 
(a) The viSNE map, colored by intensity of expression of (from top to bottom) CD34, CD33, CD64 and CD7. 
For each marker, cells were separated into two subpopulations: “on” (positive) and “off” (negative), based on 
an expression threshold (black lines). (b) Left: Biaxial plot of CD34 versus CD33. Right: Biaxial plot of CD64 




 subpopulation from the upper right quadrant of the left plot. In all 
cases, cells are colored and labeled by the quadrants. (c) Six subpopulations (the only 6 populations having 
more than 20 cells each) revealed by comparisons such as that in panel b, were projected onto the viSNE map. 
Cells are colored by their respective subpopulation from b. The relapse sample can now be sorted into these 
subpopulations via fluorescence-activated cell sorting (FACS) and further studied through downstream 





2.2.8 viSNE detects minimal residual disease  
The ability to detect, by flow cytometry, small numbers of cancerous cells displaying an aberrant 
phenotypic “fingerprint” is used to risk-stratify patients and direct treatment decisions. The 
presence of such minimal residual disease (MRD) can be associated with risk of relapse [61, 62]. 
The detection of MRD indicates a need for intensified therapy that unfortunately carries an 
increased risk of toxicity. Consequently, accurate detection of rare malignant populations is 
paramount in correctly assigning risk to an individual patient. 
There are two competing manual methods for assessing MRD by flow cytometry. The first 
involves identifying aberrant antigen expression (leukemia-associated immunophenotype, or 
LAIP) on the leukemia cells at diagnosis, and then looking for that same phenotype on samples 
taken after chemotherapy [63]. The second method involves identifying leukemic cells based on 
a ‘different-from-normal’ phenotype by comparing to a historical bank of healthy bone marrow 
samples [64]. While the prognostic value of MRD measurement has been validated in several 
clinical trials, both of these approaches require an expert pathologist to manually inspect biaxial 
plots, and both approaches have shortcomings. It can be difficult to identify abnormal cells that 
are sufficiently phenotypically distinct from normal bone marrow. If one relies on and searches 
only for cells with the phenotype of the diagnostic sample, one may fail to detect other malignant 
populations displaying distinct yet abnormal phenotypes. Thus, a tool which automatically 
identifies abnormal cellular phenotypes would allow clearer identification and evaluation of 
remaining cancer cells. 
Because viSNE revealed such a clear contrast between leukemic and healthy bone marrow, we 
tested whether viSNE could aid manual MRD detection. We spiked metal-barcoded [65] cells 





sample with 0.25% of a MRD-like population. A single healthy bone marrow sample served as a 
guide for interpretation (similar to the “different-from-normal” manual approach). We used a 
biased subsampling method to enrich for unique non-control subpopulations and generated a 
viSNE map using eight markers (CD3, CD7, CD10, CD15, CD20, CD34, CD38, CD45) to 
emulate a MRD scenario using fluorescence-based flow cytometry (see Materials and Methods). 
The algorithm was blinded to the metal-barcoded channel. 
A good MRD candidate region would be a distinct region of the viSNE map that contains cells 
from the MRD sample, but no cells from the healthy control sample. Cells from both samples 
were well-mixed across most of the viSNE map, except for one suspect region that was 
composed almost entirely from cells from the synthetic MRD sample (Figure 2-8a). We 
compared marker expression levels in the suspect region to the rest of the sample (Figure 2-8b) 
and found that the suspect cells strongly expressed CD10 and CD34, exhibited below-average 
expression of CD45 and also expressed CD15, a phenotypic combination often seen in B 
precursor ALL. Taken together, the combination of these surface markers and the absence of 
similar cells in the healthy control suggest that these were leukemic cells. Removal of the 
blinding of the metal-barcoding channel revealed that these cells were positive the metal-barcode 
and therefore were indeed the spiked ALL cells (Figure 2-8c). We repeated this analysis with a 
different set of markers and achieved similar results. As a control, we repeated the same 
procedure with an “MRD” sample that only included healthy cells. The two healthy samples 
were well mixed across the entire viSNE map; there was no region that contained only MRD 
cells, demonstrating that the subsampling method and viSNE do not spuriously create suspect 





minuscule cancer subpopulation in the data, suggesting that viSNE can be effectively used for 
MRD detection. 
 
Figure 2-8. Using viSNE to identify synthetic minimal residual disease (MRD). 
(a) A synthetic MRD sample was created by spiking a healthy bone marrow sample with metal-barcoded ALL 
cells. This synthetic MRD sample was compared to an unmanipulated healthy bone marrow sample (the viSNE 
algorithm was blinded to the metal-barcode channel). The viSNE map of the synthetic MRD sample (purple) 
and a healthy control sample (cyan) includes a suspect region (marked by an arrow) composed almost entirely 
of cells from the synthetic MRD sample (purple). (b) Expression of indicated markers on cells in the suspect 
region (red) and the non-suspect region (cyan). X-axis represents marker expression level and y-axis represents 
density of cells. (c) The viSNE map from panel a, after removing the blinding of the metal-barcoding channel. 
The map is color according to expression of the metal barcode in the spiked-in ALL cells (red). The suspect 
region is indeed almost entirely composed of ALL cells. ALL cells outside of the suspect region have marker 
expression levels conforming to healthy cells. 
2.3 Comparison of viSNE to other methods 
viSNE belongs to the class of nonlinear dimensionality reduction (NLDR) algorithms which, 
unlike principal component analysis (PCA), do not assume linear relationships between 
parameters. Immune subsets are nonlinear and hence PCA, unlike viSNE, fails to separate 
between them (Figure 2-9). We evaluated three other NLDR algorithms [66]: Isomap [44], LLE 
[50] and Kernel PCA [47] (Figure 2-9). Out of the three, both LLE and Kernel PCA collapsed all 
of the data points into a single region (in the case of LLE) or into three to five diagonals (in the 
case of Kernel PCA). Both of these phenomena have been described before [25] and are caused 





methods. Isomap is the only other method that managed to separate between the different 
immune subtypes. However, the separation is weaker than viSNE: the two T-cell subtypes 
overlap, and the unclassified cells are a smudge that covers most of the low-dimensional space. 
Furthermore, Isomap suffers from lack of robustness, as different runs lead to qualitatively 
different outputs. Additionally, these methods might be confounded by the noise inherent in 
biological systems and measurement technologies or by the complex geometry in high-
dimensional hematopoietic space. 
 
Figure 2-9. Comparison of four dimensionality reduction algorithms (PCA, Isomap, LLE and Kernel 
PCA) to viSNE over three subsamples of Marrow1. 
Cells are color coded by immune subsets, as in Figure 2-1b. We found similar results for additional NLDR 
algorithms from the toolkit [25]. 
Another method that has been used in the context of mass cytometry is SPADE [12, 56]. SPADE 





SPADE suffers from two flaws when compared to viSNE. One, SPADE begins by down-
sampling the data using a density-based, non-uniform random process. The algorithm is not 
robust to this down-sampling step, and as a result multiple runs can lead to radically different 
outputs (Figure 2-10). Other than prior knowledge, there is no way to judge which SPADE run 
leads to the correct interpretation of the system, a significant disadvantage when applying the 
algorithm to a less-familiar system. Two, SPADE’s second step is clustering the data, losing the 
single-cell resolution. This clustering step is not sensitive to rare cell populations; for example, 
when we applied SPADE to the same synthetic MRD sample as viSNE, the ALL cells were 
indistinguishable from healthy cells in the resulting SPADE tree (Figure 2-11), rendering 







Figure 2-10. Two SPADE runs of Marrow1, colored by mean marker expression levels for each cluster. 
In this plot each point is a cluster of cells and edges represent the minimal spanning tree identified by SPADE. 
Each row represents one of the two SPADE runs and each column representes the marker whose mean value 
was used to color the clusters. Clusters group by immune subtype, but longer range distances are less 
conserved between runs, resulting in considerable differences between the SPADE tree from the two runs. 
 
Figure 2-11. SPADE was applied to the same synthetic MRD sample used in Figure 2-8. 
The ALL-barcoded cells (the target cells) are spread over 3 different clusters (marked with arrows); the cluster 
with the highest percentage of ALL-barcoded cells is marked with a black arrow- approximately 90% of its 
cells are from the MRD sample (the remaining 10% are from the healthy control sample). However, there are 
73 clusters that fit the 90% MRD criterion (red clusters), and the 3 ALL-barcoded-rich clusters do not stand 





viSNE has a number of advantageous features for the analysis of single-cell data which lead it to 
succeed where the other methods failed. viSNE models the local neighborhood by examining all 
pairwise pro-Babilities, not just a subset that is defined by a user-provided threshold. This results 





 T cells. Additionally, viSNE has been designed with the curse of dimensionality 
in mind. As a result, the choice of a t-distribution makes the algorithm much more sensitive to 
small subsets, allowing us to subsample uniformly (thus preserving the original frequencies of 
cell populations), and leading to the detection of rare populations such as in the MRD settings. 
Finally, viSNE does not cluster the data, keeping the single-cell resolution and allowing us to 
visualize each individual cell. We can visualize marker levels, including signaling markers, on 
top of the viSNE map. viSNE’s design philosophy is unique in the field of nonlinear 
dimensionality reduction, making it the best current choice for analysis of high-dimensional 
single-cell data. 
2.4 Discussion 
viSNE allows visualization of high-dimensional single-cell data on a two-dimensional map. This 
mapping takes advantage of the inherent structure of the data; for example different immune 
subsets reside in separate regions in high-dimensional space. Conventional analysis of cytometry 
data, which views only two dimensions at a time, ignores the higher-order structure and complex 
relationships between markers in the data. Whereas viSNE plots resemble conventional biaxial 






We found that the viSNE map is consistent across multiple healthy individuals, while cancer 
samples occupy regions distinct from healthy cells and from each other. We illustrated how 
viSNE can be utilized to characterize heterogeneity within cancer samples, mark disease 
progression from diagnosis to relapse, and identify rare cancer populations lurking among 
predominantly healthy cells.  
Despite its extensive utility, as with all dimensionality reduction tools viSNE is inherently 
limited: low-dimensional mapping cannot represent all of the information in high-dimensional 
space. Therefore, viSNE only captures the most dominant structures. One way to gain more 
detail is to run viSNE on a well-defined subset of the data. For example, instead of analyzing 
several cancer samples together (Figure 2-3d), one can run viSNE on each sample separately 
(Figure 2-5a-b). Alternatively, it is possible to limit the mapping to only a subset of parameters 
of interest. Another consequence of dimensionality reduction is the “crowding pro-Blem”, which 
typically limits the number of cells we can map to 30,000. This limits applications such as 
gating, since a subsampling of the cells is required, meaning only cells in the subsample can be 
classified. An effective solution for gating is combining viSNE with a clustering algorithm. We 
clustered the cells using FLOCK [57], a state-of-the-art clustering tool for cytometry data, and 
labeled the viSNE map according to this clustering (Figure 2-12). While FLOCK separated the 
immune subtypes, it splits each subtype into multiple clusters. The viSNE map helps interpret 






Figure 2-12. FLOCK clustering of mass cytometry data [57], as visualized by viSNE, each cell is colored 
by its cluster id. FLOCK separates the major subtypes. 
However, it suffers from over-clustering and breaks most cell subtypes into multiple clusters. The viSNE maps 
helps regroup these back together for interpretation. 
viSNE is an unsupervised algorithm and does not require prior knowledge of the system. It is 
thus suitable for navigating less explored systems such as cancer. While structure in healthy 
samples is formed through an orderly program of development, cancer’s derailed developmental 
program leads to loss of normal order and structure. viSNE helps characterize the plethora of 
abnormal phenotypes unique to each cancer by exploiting its ability to take all markers into 





A characteristic feature that repeated across multiple cancer maps was the emergence of distinct 
gradients of marker expression levels that resemble developmental progression in healthy cells 
(Figure 2-1d). Comparing gradients in AML diagnosis and relapse samples (Figure 2-6b) 
supports the notion that the cells first gain CD34 and subsequently the cells acquire a large 
diversity of abnormal combinations of lineage-specific markers without attenuation of CD34. 
After identifying unexpected cancer populations using viSNE, one can design a sorting strategy 
for physical isolation and downstream characterization of these populations.  
In the future, we expect viSNE to be instrumental in the analysis of mass cytometry data 
integrating the surface marker panel with a panel of functional markers that pro-Be signaling, 
cell cycle and metabolism, under many experimental perturbations (such as cytokines and drugs) 
[3]. In this scenario, viSNE’s ability to distinguish rare subsets which comprise only a tiny 
fraction of the population (Figure 2-8) could be advantageous toward the identification and 
characterization of rare drug resistant subpopulations.  
We demonstrated viSNE’s capability to analyze mass cytometry and flow cytometry data. 
Biological research is trending towards dozens of dimensions in tens of thousands of cells. 
Making sense of these data is a daunting challenge that requires powerful computational 
approaches. The utility of viSNE will increase with the number of dimensions capable of being 
analyzed by mass cytometry and other technologies. 
2.5 Materials and Methods 
2.5.1 The t-SNE algorithm 
The t-Distributed Stochastic Neighbor Embedding (t-SNE) algorithm maps points from high-





similarities between points in high- and low-dimensional spaces [67]. The axes of the low-
dimensional spaces are given in arbitrary units. The algorithm proceeds as follows. 
t-SNE’s input is a list of points in high-dimensional space, X. The algorithm begins by 
calculating the pairwise similarity matrix in high-dimensional space, P, and randomizing a 
starting position for each point in the low-dimensional space, Y0. t-SNE proceeds to iteratively 
update the position of points in low-dimensional space: in iteration i, the similarity matrix in 
low-dimensional space, Q, is calculated according to the points’ current positions (Yi-1). Gradient 
descent is used to calculate the new position of each point, Yi, in order to minimize the 
divergence between P and Q. 
For each point xi in high-dimensional space, t-SNE defines the similarity of xi to xj as defined 
below: 
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 (Equation 1) 
σi is xi’s variance. For each xi, t-SNE performs a binary search for the value of σi that produces a 
Pi with a fixed Perplexity (a parameter for the algorithm that is given by the user; an intuitive 
interpretation for the perplexity is a soft measure for the number of nearest neighbors to consider 
for each cell). The Perplexity is defined as: 
          
      (Equation 2) 
where H(Pi) is Shannon’s entropy: 
       ∑               (Equation 3) 





    
         
  
 (Equation 4) 
For each pair of points in low-dimensional space, yi and yj, the similarity is defined as: 
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 (Equation 5) 
While pij follows a Gaussian distribution, qij is calculated using a t-distribution. 
t-SNE minimizes the Kullback-Leibler (KL) divergence between the joint pro-Bability 
distribution P (in the high-dimensional space) and the joint pro-Bability distribution Q (in the 
low-dimensional space). The KL divergence is defined as: 
         ∑ ∑       
   
   
   (Equation 6) 
The gradient of the KL divergence between P and Q is derived in [67]: 
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     (Equation 7) 
The optimization step may be interpreted as a set of springs. Each pair of points Yi and Yj is 
connected by a spring which repels or attracts the points from each other depending on whether 
the similarity between the points in the projection is lower or greater than the similarity in the 
high-dimensional space. The gradient reduces each point’s springs into a single force. The heavy 
tailed t-distribution helps alleviate the “crowding pro-Blem” by exerting more force when 
pushing distant points further apart. 
2.5.2 The viSNE implementation 
viSNE is a distributed implementation of t-SNE that relies on the locality of t-SNE’s 





n/N points. Each core receives one partition. Instead of storing the entire matrix (n
2
 values), each 
core only stores the submatrix consisting of its n/N points, times all other points (n
2
/N values). 
For example, for n = 100,000 and N=64 cores, each core will need to store approximately 150 
million values per matrix. For each iteration, each core locally updates Yi for points in its 
partition and broadcasts these values to the other cores, guaranteeing that all cores have the 
updated similarity matrix. 
The robustness and accuracy of t-SNE derives from the computation of all pairwise similarities. 
But, the similarity matrix comes at a heavy computational price, limiting the original 
implementation to 10,000 points. Our distributed implementation relies on the fact that each of t-
SNE’s computations are local and do not require the entire matrix. The technical computational 
limit of viSNE is 100,000 points. However, beyond 30,000 the limit is not computational, but 
rather the “crowding pro-Blem” [67]: the volume in high-dimensional space grows polynomial 
with the number of dimensions, and as a result a two-dimensional map cannot accommodate a 
large number of points while conserving the high-dimensional distances between them. Instead, 
distant points collapse onto nearby areas of the map, creating one large, dense region, with no 
separation between populations. To solve this, viSNE subsamples cells uniformly at random and 
maps the sampled population. The algorithm is robust to such subsampling and even after 
subsampling, we still detect rare subpopulations that constitute a mere 0.2% of the population. 
2.5.3 The cyt visualization tool 
cyt is an interactive visualization tool designed for the analysis of viSNE maps and the high-
dimensional mass or flow cytometry data from which these maps were projected. It plots viSNE 
maps as scatter and density plots, and information can be overlaid onto this map by coloring cells 





includes a gating feature that can be used with either biaxial plots (to generate a viSNE map on 
only a defined subset of the cells) or the viSNE map (to further study a population identified by 
viSNE). This is enabled by cyt’s modular design: once a gate is created it can be treated as an 
independent dataset and all of cyt’s features can be applied. The gates can be compared on a 
marker-by-marker basis using one-dimensional density plots, and cyt prioritizes the markers 
according to the L1 distance between marker distributions. This method quickly identifies key 
differences between populations. The combination of viSNE and cyt facilitates efficient 
examination of mass and flow cytometry data. 
cyt contributes in correlating multiple viSNE maps of the same data. While viSNE consistently 
separates the various immune subtypes, their position on different maps could vary (most often 
due to rotations and reflections of the map). In healthy samples, we initially colored the immune 
subtypes using cyt, helping us label each sub-population and therefore compare between 
different viSNE maps of similar data. While the maps can vary in rotation and reflection, the 
actual population structure is preserved and cyt can be used for re-orientation. For cancer 
samples, which lack distinct subtypes, cyt lets us quickly identify which populations are similar 
to each other between multiple maps of the same sample based on their marker combination. cyt 
presents the data in an intuitive visual manner that allows the user to corroborate the viSNE 
maps. 
Alternatively, to get multiple samples projected onto the exact same map, we can run a number 
of samples together in a single run of viSNE. This approach was used to generate Figures 2-3b 
and 2-3d. cyt can then be used to split these into multiple maps, one for each sample, that share 
coordinates (Supplementary Fig. 5). The advantage of running multiple samples together is one 





2.5.4 Mass cytometry data 
Fresh, Ficoll-enriched human bone marrow was obtained from healthy donors from AllCells, 
Inc. (Emeryville, CA). Samples were obtained with informed consent in accordance with the 
Declaration of Helsinki and with accordance with Stanford University’s review board. Leukemia 
bone marrow samples were obtained under IRB-approved protocols (protocol number 17552 
under Stanford University’s IRB) at St. Jude Children’s Research Hospital, Memphis, TN 
(pediatric acute myeloid and lymphoblastic leukemia) or at Princess Margaret Hospital, Toronto, 
ON (adult acute myeloid leukemia). All samples were deidentified. The age and the sex of the 
donor, or any additional clinical information, were unknown at the time of the study. 
Samples were processed as described in Bendall et al [12]. Briefly, cells were used fresh prior to 
mass cytometry experiments, or frozen in FCS with 10% DMSO, thawed and re-suspended in 
90% RPMI with 10% FCS (supplemented with 20 U/mL sodium heparin (Sigma) and 
0.025U/mL benzonase (Sigma) in the case of frozen samples), 1X L-glutamine and 1X 
penicillin/streptomycin (Invitrogen). 
Cells were fixed with formaldehyde (PFA; Electron Microscopy Sciences, Hatfield, PA) added 
directly to growth media at a final concentration of 1.6% for 10 minutes at room temperature. 
Cells were then centrifuged at 500g for 5 minutes and washed once with staining media (PBS 
with 0.5% BSA, 0.02% sodium azide) to remove residual PFA, and blocked with Purified 
Human Fc Receptor Binding Inhibitor (eBioscience Inc., San Diego, CA) following 
manufacturer’s instructions. Surface marker antibodies were added yielding 50 or 100 uL final 
reaction volumes and stained at room temperature for 30min (Table 2-2). Following staining, 
cells were washed 2 more times with cell staining media, permeabilized with 4°C methanol for at 





cell staining media to remove remaining methanol, and stained with surface and phospho-
specific antibodies in 50 or 100 μL for 30 min at room temperature. Cells were washed once in 
cell staining media, then stained with 1 mL of 1:5000 191/193Ir DNA intercalator(2) 
(www.dvssciences.com; DVS Sciences, Richmond Hill, Ontario, Canada) diluted in PBS with 
1.6% PFA for 20 min at room temperature. Cells were then washed once with cell staining media 






Target Clone Metal Isotope Staining Concentration (ug/ml) 
CD10 HI10a (BL) 156 Gd 1 
CD114 LMM741 (BL) 156 Gd 2 
CD117 104D2 (BL) 171 Yb 1 
CD11b ICRF44 (BL) 144 Nd 3 
CD11c 3.9 (BL) 154 Sm 5 
CD123 9F5 (BD) 151 Eu 3 
CD13 L138 (BD) 168 Er 1 
CD133 AC133 (MB) 141 Pr 3 
CD14 M5E2 (BL) 160 Gd 2 
CD15 W6D3 (BL) 164 Dy 2 
CD16 3G8 (BL) 165 Ho 2 
CD161 HP-3G10 (BL) 150 Nd 5 
CD179a HSL96 (BL) 149 Sm 2 
CD19 HIB19 (BD) 142 Nd 1.5 
CD2 TS1/8 (BL) 152 Sm 0.5 
CD20 2H7 (BL) 147 Sm 3 
CD20 cytosolic H1 (BD) 147 Sm 3 
CD22 HIB22 (BL) 168 Er 1 
CD235a/b HIR2 (BL) 141 Pr 2 
CD3 S4.1 (QD) 110 Cd 1:200 
CD3 UCHT1 (BL) 170 Er 0.5 
CD33 P67.6 (BD) 158 Gd; 173 Yb 1.5 
CD34 8G12 (BD) 148 Nd 3 
CD38 HIT2 (BL) 159 Tb; 168 Er 1 
CD4 RPA-T4 (BL) 145 Nd 3 
CD41 HIP8 (BL) 152 Sm 1 
CD44 G44-26 (BD) 166 Er 1 
CD45 HI30 (BL) 115 In; 154 Sm 2 
CD45RA HI100 (BL) 139 La 3 
CD47 B6H12 (BD) 145 Nd; 172 Yb 2 
CD49d 9F10 (BL) 144 Nd 1 
CD5 UCHT2 (BL) 154 Sm 1 
CD56 B159 (BD) 170 Er 2 
CD61 VI-PL2 (BD) 169 Tm 0.25 
CD64 10.1 (BL) 153 Eu 1 
CD7 M-T701 (BD) 167 Er 2 
CD79b CB3-1 (BL) 146 Nd 2 





CD90 5E10 (BL) 176 Yb 5 
CXCR4 12G5 (BL) 175 Lu 3 
Flt3 BV10A4H2 (BL) 150 Nd 2 
HLA-DR L243 (BL) 174 Yb 2 
IgD IA6-2 (BL) 145 Nd 1 
IgM G20-127 (BD) 153 Eu 2 
pre-BCR HSL2 (BL) 165 Ho 3 
TdT E17-1519 (BD) 151 Eu 3 
TIM-3 344823 (RD) 169 Tm 1 
 
Table 2-2. Antibody sources, metal isotope and staining concentration for all of the antibodies used 
throughout the various experiments. 
Vendors: Invitrogen Qdot655 (QD); Biolegend (BL); BD Biosciences (BD); Miltenyi Biotec (MB); R&D 
Systems (RD); DVS Sciences (DVS); VWR International (VWR); eBioscience (EB); Cell Signaling 
Technologies (CST). 
2.5.5 Processing of mass cytometry data 
Data was transformed using hyperbolic arcsin with a cofactor of five. Single cells were gated 
based on cell length and DNA content (to avoid debris and doublets) as described in Bendall et 
al. [12]. The expert manual classification of Marrow1 was taken from [12], where the complete 
biaxial plot gating strategy can be found.  
2.5.6 viSNE analysis 
Generating viSNE maps included the following steps (exact details can be found in Table 2-1). 
First, between 6,000 and 12,000 cells were uniformly subsampled from the data. After 
subsampling, viSNE was run for 500 iterations to project the data into 2D. Unlike t-SNE, PCA 
was not used as a preprocessing step. All runs used an identical random seed and the default t-
SNE parameters (perplexity = 30, momentum = 0.5 for initial 250 iterations, momentum = 0.8 
for remaining iterations, epsilon = 500, lie factor = 4 for initial 100 iterations, lie factor = 1 for 
remaining iterations). viSNE maps were visualized using cyt, which was also used to generate 
figures (color coding by immune cell subset (as in Figure 2-1b), by marker expression levels (as 





2.5.7 Quantifying similarity between viSNE maps 
We use the Jensen-Shannon (JS) divergence to quantify the similarity between viSNE maps. 
Each map is converted into a pro-Bability distribution. We define the similarity between two 
maps as the JS divergence between their respective distributions: 
                               (Equation 8) 
Where M is: 
          (Equation 9) 
And KL is the Kullback-Leibler divergence: 
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   (Equation 10) 
The JS divergence has a value of between zero and one. When JS(P||Q)=0, the pro-Bability 
distributions are identical. When JS(P||Q)=1, there is no overlap in the information encoded by P 
and Q. 
2.5.8 A gating scheme for fluorescence-activated cell sorting 
The viSNE map was utilized to devise a gating scheme for fluorescence-activated cell sorting 
(FACS) of the AML relapse sample (Figure 2-7). Due to the limits of flow cytometry, the gating 
scheme can only employ a limited number of channels and use hard thresholds. Through manual 
inspection of the viSNE map we identified four markers that lead to distinct subpopulations 
which could be of interest for downstream analysis: CD34, CD64, CD33 and CD7 (Figure 2-6). 
For each marker we defined a threshold for a binary negative/positive gate. The four binary gates 





combinations. Only 6 composite gates had more than 20 cells. The cells residing in each of these 
6 composite gates are color coded on the viSNE map of Figure 2-7. 
2.5.9 Subsampling of synthetic MRD sample 
We used two samples: the synthetic MRD sample (composed of 99.5% healthy bone marrow 
cells and 0.5% cells from a metal-barcoded ALL sample) and the control sample (100% healthy 
bone marrow cells taken from a different donor). To capture a higher proportion of ALL cells for 
the viSNE map, we devised the following subsampling procedure. The cells from the synthetic 
MRD sample and from the control sample were combined computationally and clustered using 
the Louvain algorithm [68]. Next, the clusters were weighted by the proportion of synthetic 
MRD sample cells in them; the higher the proportion of synthetic MRD sample cells, the higher 
the weight. Finally, 10,000 cells were chosen one at a time in a two-step process: one of the 
clusters was chosen randomly (biased by cluster weight) and a cell was uniformly chosen from 
that cluster. Note, the subsampling procedure is blind to the metal barcode; it can only access the 
mass cytometry measurement and the identity of the sample (synthetic MRD or control). 
Following the subsampling, viSNE was run as described above. 
2.5.10 Additional algorithms 
Isomap, LLE, KernelPCA and LLTSA were run using the Matlab Toolbox for Dimensionality 
Reduction [25]. FLOCK was compiled from the code available in the ImmPort FLOCK 
SourceForge page (http://sourceforge.net/projects/immportflock/). SPADE was run using the 







Chapter 3 The Wanderlust algorithm for 
trajectory detection 
3.1 Introduction 
3.1.1 The developmental trajectory 
Given a healthy bone marrow sample composed of B-lineage cells, the developmental trajectory 
is the ordering of cells according to their developmental chronology. We can use the trajectory as 
scaffolding, upon which we can infer the order of key molecular and cellular events during 
development. For example, the transition between stages will be seen as a decrease in the levels 
of early-stage markers and an increase in later-stage markers. Proliferation, apoptosis, and the 
signaling involved in regulating development will all be reflected in changes in respective 
marker levels. The trajectory can also serve to characterize the timing of poorly-understood 
markers by examining changes in their expression relative to better understood markers.  
There are several challenges underlying trajectory detection. These will be briefly described here 
and fully explored in the following paragraphs. First and foremost, the data is rife with statistical 
noise from multiple sources, both biological and technical; the most detrimental effect of this 
stochastic variation is the creation of short circuits- pairs of cells which are developmentally 
distant but close in the space of measured parameters. Second, the data involves several rare sub-
populations that comprise a tiny portion of the data (often less than 1%); many approaches might 
incorrectly treat these as outliers, losing crucial regions of the trajectory. Third, the data is high-





cannot physically visualize all of the required dimensions; additionally, computational methods 
should be able to scale to the large number of dimensions and cells in this data. Fourth, marker 
levels rise and fall in a coordinated fashion and their multivariate relations cannot be faithfully 
captured in a linear model, hence a successful computational approach must be non-linear in its 
nature. Fifth, cell size influences the measurement of all other measured parameters, leading to 
the appearance of spurious relationships in the data. We now elaborate on each of these points.  
Biological data includes statistical noise from multiple sources, which can be broadly classified 
into two categories. The first, stochasticity, is the noise inherent to the biological system due to 
the small quantities of the molecules involved (sometimes as low as only a few copies of a 
molecular epitope per cell [70, 71]). The second, technological noise, is caused by imprecisions 
and limitations of the technology used. While some of it can be identified and compensated for 
via pre-processing, there is much variation that cannot be accounted for.  
Noise raises a variety of pro-Blems for analysis and method development. For example, cells that 
are developmentally close might have different measurements. Vice versa, developmentally 
distant cells might appear similar to each other, a phenomenon we call a short circuit (figure 3-
1a). A third implication, which is common to antibody-based technologies, is scaling: since 
antibodies have different binding affinities and molecular properties, antigen measurements can 
only be given in arbitrary units; it is impossible to compare exact amounts and the magnitude is 
different between antigens and between samples. 
Another challenge is that some rare cell stages, such as stem cells, comprise less than a tenth of a 
percent of the population. Computational methods might classify such cells as outright outliers 





sample comprising hundreds of thousands of cells is required to guarantee that enough cells from 
each rare population are present, necessitating a computationally efficient algorithm to find the 
trajectory in a reasonable amount of time. 
Another complication is the influence of cell size on marker measurements. Biological processes 
are concentration-based and therefore larger cells usually have more copies of required 
molecules. Without a reliable indication of cell size, it is impossible to differentiate between a 
large cell with relatively few copies of a molecule and a small cell with a high concentration of 
it, although the two might differ functionally. Two final, interwoven complications are the high-
dimensionality of the data and the non-linear relationships between parameters (figure 3-1b). The 
large number of dimensions necessitates a computationally light method in order to receive 
results in a reasonable amount of time. However, the non-linear models required to correctly 
model the system are often complex and computationally intensive. 
In summary, a successful method should be robust to the noise in the data, identify the rare cell 
subsets, consider relative rather than absolute marker amounts and accommodate, the nonlinear 






Figure 3-1. Non-linear relationship between markers. 
(a) A toy example showing a short circuit. Black edges are biologically correct edges. The dashed red edge is a 
short circuit caused by a short distance in high-dimensional space due to noise. The correct graph walk (in red) 
will be superseded by the short circuit. (b) CD10 (x-axis) versus CD20 (y-axis) in B lineage cells. Grey dots 





 stem cells are followed CD10
+
 progenitors; as cells mature, CD10 
decreases while CD20 goes up. This process cannot be modeled by a linear relationship between CD10 and 
CD20. 
3.1.2 Overview of existing methods 
While a method that explicitly detects a trajectory does not exist, several computational methods 
rise as promising candidates for this task. PCA [29], Isomap [44], Kernel PCA [47] and other 
dimensionality-reduction methods have been covered in chapter 2; however, as described there, 
these either assume a linear relationship between parameters or do not scale to a large enough 
number of cells. Furthermore, none of them directly address the task of detecting a trajectory. 
Likewise, SPADE [56], which was also discussed in chapter 2, is non-robust and does not scale 
to the necessary number of cells; it also involves subsampling and up-sampling steps, both of 
which  lose information and distort the data. 
Ergodic rate analysis (ERA) [72] is a method designed for calculating the rate of molecular 





reduction step that could conceptually be applied to trajectory detection. However, the 
integration that underlies this step assumes that the number of cells of a given stage is 
proportional to the amount of time spent in that stage. This ergodic assumption is broken in the 
case of a developmental system, where proliferation rates vary, rapid proliferation is followed by 
rapid cell death, and where cell subtype proportions are influenced by many factors (such as 
genetics and exposure to pathogens). Furthermore, ERA involves the calculation of the density 
function underlying the data, an operation whose computation speed scales exponentially with 
the number of dimensions. We note that ERA has only been successfully applied to a maximum 
of four dimensions.  
Projection pursuit (PP) [73, 74] is an exploratory analysis method that aims to find interesting 
low-dimensional views (linear projections) of the data. The experimenter then visually examines 
the projections in an attempt to find those which include a relevant signal. PP requires a function 
I, called a projection index. I quantifies the how interesting a projection is. The algorithm then 
samples projections of the data and finds a set of projections with high I. Several papers explore 
possibilities for I and the sampling process [75-78], and the algorithm has been applied in 
contexts such as chemistry [79, 80], ecology [81], meteorology [82], and biology [83, 84]. 
However, PP suffers from three major shortcomings: first, it is based upon linear projections and 
as such cannot handle the non-linear relationship in developmental data; second, the algorithm is 
sensitive to the choice of projection index and sampling method [74]; and third, the algorithm is 
computationally intensive, as evidenced by the small number of data points (in the low hundreds) 






3.2.1 A graph-based approach to trajectory detection 
To develop an appropriate trajectory detection algorithm, we make three assumptions about the 
data. First, a large healthy bone-marrow sample taken at a single time point will include cells 
throughout the entire continuous developmental process, including intermediate and rare cell 
populations. Second, B cell development in the marrow is non-branching and linear: cells can 
either proceed along development or undergo apoptosis. Third, B cell development is 
continuous; changes in protein expression are gradual, and therefore the transitions between 
stages are gradual. Given these assumptions, we can measure the levels of all of the markers 
needed to identify the different stages in millions of cells and should then be able to trace the 
trajectory. 
Based on these assumptions, we propose a graph representation of the data as a conceptual 
framework for a trajectory detection algorithm. We convert the data into a k-nearest neighbor 
graph (k-NNG). Each cell is represented as a node and is connected to its k neighbors, the cells 
most similar to it, via an edge whose weight is set by the similarity. We define the shortest-path 
distance between a pair of cells as the length of the path between the nodes that minimizes the 
sum of weights of its constituent edges. The shortest-path distance is composed of transitions 
through neighbors, where each transition is a small gradual step. A conceptual design for a 
trajectory detection algorithm would be to start from the earliest cell in the data and order the rest 
of the cells according to their shortest-path distance from that earliest cell. Based on our third 





The graph representation addresses several of the data’s pro-Blems. The conversion into a graph 
is cheap, and shortest-path calculations are fast due to the graph’s sparsity; this enables the 
analysis of large datasets in reasonable time [85]. Our model is based on similarity between cells 
rather than on relationships between parameters and can therefore handle non-linearity. The 
magnitude of the noise is proportional to the distance and since the local neighborhood is based 
on short distances this approach is less susceptible to noise (since short distances are reliable, and 
our representation of long distances as graph traversal mitigates noise from long distances). 
Finally, even if two developmentally close cells are not direct neighbors they still reside in the 
same region in the high-dimensional space. Therefore, they will be separated by a small number 
of close neighbors and the shortest-path distance between them will be low, circumventing much 
of the unexplained variability in the data. 
However, the k-NNG is still susceptible to short circuits as such cells might be connected via an 
edge. The shortest-path between developmentally distant cells will go through the short circuits, 
leading to incorrect distances. A possible solution for this pro-Blem is to use a random-walk 
based distance measure. However, random walks are computationally intensive as they go both 
towards and away from the target and are not practical in such a large graph. Instead, we fight 
fire with fire and utilize randomness to address the noise in the data. Short circuits are rare; 
therefore, a random subset of the graph is likely to include only a few short circuits. We extend 
the graph representation into an ensemble of l-out-of-k-nearest neighbor graphs (l-k-NNG)
1
. An 
l-k-NNG is generated by starting with the k-NNG and iterating over each node in the graph, 
randomly keeping only l of its k-nearest neighbors. On average, a given short circuit will only 
exist in 2l/k of the graphs (the pro-Bability that that specific edge will be one of the l edges 
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chosen out of the k edges, for each of the two nodes that the edge connects); in these graphs the 
shortest-path distances will be distorted by that short circuit. By picking l lower than k, each 
short circuit only appears in a few l-k-NNGs and influences a different set of cells. We can 
average out its effect by taking the mean over all graphs. 
Shortest-path distances raise two complications. First, distances do not have a direction while the 
trajectory does. In order to address this issue, we require a user-defined early cell. The early cell 
is assumed to reside toward the beginning of the trajectory and is used for orientation. Second, 
the shortest-path distance variability increases with the distance. As nodes get farther from each 
other, the accuracy of their short-path distance decreases, since mistakes accumulate. Therefore, 
the distance between two distant cells is less reliable than between two close cells. We utilize 
landmarks to support our trajectory by breaking it into shorter distances. We randomly flag a 
small subset of as landmarks, following a uniform distribution. In the naïve approach only the 
early cell was used to decide on each other cell’s position. The landmark cells serve as 
reinforcements to the early cell: the position of each cell will now be calculated as the average of 
its distance from all of the landmarks. Additionally, we weigh the contribution of each landmark 
according to its distance from the cell, further reinforcing the influence of short distances and 
reducing the influence of long distances. Since at least some of the landmarks will be close to the 
cell, this allows us to get a better approximation of its position. 
3.2.2 An outline of Wanderlust 
Wanderlust begins with a two-step initialization step (Figure 3-2, top left). First, a set of cells is 
randomly chosen as landmarks. Then, the data is transformed into an ensemble of l-k-NNGs. The 
algorithm proceeds by iteratively calculating the trajectory in each of the graphs separately: for 





shortest-path distance from a user-defined early cell s. The target’s position is refined according 
to the shortest-path distance from each landmark. The distances are weighed so that landmarks 
closer to the target contribute more to the calculation (as they are less susceptible to the noise 
inherent in the shortest-path distance). However, the landmarks are themselves cells. Therefore, 
their position will change following the refinement based on the same calculation that was 
applied to the rest of the cells. Since cell positions depend on landmark positions, the shift in 
landmarks might obsolete the new calculated positions. Therefore, the refinement step is 
repeated with the new landmark positions until the positions of all cells converge. Once the 
trajectory calculation step completes in all of the graphs, the output trajectory is set to the 






Figure 3-2. Description of the Wanderlust algorithm. 
The input data is presented as the toy scatter plot to the top left. The order of the arrows follows the different 
stages of the algorithm. First, Wanderlust transforms the data into an ensemble of graphs, and flags a random 
subset of cells as landmarks (marked in purple). The list of landmarks is constant for the rest of the run of the 
algorithm. Calculation proceeds separately for each graph (portrayed for the highlighted graph here). In each 
graph, a user defined early cell (marked in red) is used to calculate an orientation trajectory. The orientation 
trajectory is iteratively refined using the landmarks. The final trajectory score is an average over the trajectory 
of all graphs. In order to examine trends across the trajectory, we define the trace of each marker as the median 
marker intensity in overlapping windows across the trajectory. 
3.2.3 Formal description of the Wanderlust algorithm 
Wanderlust receives as input a list of N points in D dimensions. Each point is a cell represented 
by a vector of length D, where each element is a measurement of the intensity of one marker. 
The algorithm assumes that the cells lie upon a one-dimensional developmental trajectory. In 





detection. As its name implies, s is expected to originate from the beginning of the trajectory. For 
each cell, Wanderlust outputs a continuous trajectory score which provides the cell’s temporal 
position across development: s has a score of zero and the most mature cell has a score of one, 
with the rest of the cells in between. Section 3.2.4 includes a pseudo-code of the algorithm 
including a summary of user-supplied parameters. 
Wanderlust is composed of two steps: an initialization step and an iterative trajectory detection 
step. In the initialization step, Wanderlust flags a set of cells to serve as landmarks. The 
landmark selection is done uniformly at random and therefore uses no prior information about 
the data its underlying developmental process. The landmarks buffer against noise: each cell is 
going to have landmarks nearby, reducing the variability in calculating its position across the 
trajectory. 
Next, the data is converted to a k-nearest-neighbor graph (k-NNG): each cell is represented by a 
node and is connected via an edge to the k cells most similar to it. The edge weights are equal to 
the distance between the two nodes. The graph is represented as an adjacency matrix, where each 
row and each column are a cell, and the value at position (k, l) corresponds to the weight of the 
edge between nodes k and l [86]. The k-NNG is used as a template for the generation of an 
ensemble of l-out-of-k-nearest-neighbor graphs (l-k-NNG). A single l-k-NNG is generated by 
randomly and uniformly picking l neighbors out of the k-nearest-neighbors for each cell. As with 
the landmarks, the construction of a random ensemble mitigates noise, since a spurious edge in 





After landmarks have been chosen and the l-k-NNG ensemble constructed, the trajectory 
calculation step begins. This is an iterative process that is done separately for each l-k-NNG. 
First, we define the shortest-path distance between each pair of nodes (s, t) as: 
                                ∑    
   
 
where P is a path between s and t, e is an edge and w(e) is the weight of e. We calculate the 
shortest-path distances using Dijkstra’s algorithm [85] which has a running time of 
O(|E|+|V|log|V|), when |E| is the number of edges and |V| is the number of nodes. Briefly, 
Dijkstra’s algorithm initializes the distance from s to all other nodes in the graph to infinity. The 
algorithm recursively scans the graph, at each step updating the distances to any nodes that can 
be reached. The algorithm stops when t is reached. 
For each cell, the trajectory score is initialized to the shortest-path distance to that cell from the 
early cell that was supplied as a parameter to the algorithm. We define this score as the initial 
orientation trajectory. 
Next, for each cell (referred to as target), the shortest-path distance is calculated between each 
landmark and the target. However, distance does not have a direction: we cannot separate 
between the cases where the target precedes a landmark and where the target follows a landmark 
(figure 3-3, top and center). Therefore, an orientation step follows, where we utilize the initial 
orientation trajectory to decide on cell ordering relative to each landmark (figure 3-3, bottom): 
given early cell s then for each target cell t and landmark l, 
if d(s,t) < d(s,l) : t precedes l 





Additionally, graph traversal is in itself a source of noise and is proportional to the shortest-path 
distance: as the distance between two nodes increases many more possible paths exist between 
them, leading to higher variance in the traversed distance. Therefore, the distance from the target 
to a nearby landmark has lower variability than the distance to a distant one. This can be 
leveraged in minimizing the noise by defining a weight for each landmark:  
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The summation at the denominator is over all target cells m; the weight of each landmark is 
exponentially proportional to its distance from the target. The trajectory score for t is the 
weighted average over all landmark distances: 
      ∑
      
  
    
 
 
where the summation is over all landmarks l and nl is the total number of landmarks. In this 
weighing scheme closer landmarks, whose distance to the target is less noisy, have a higher 
weight in its trajectory score.. 
During this step the starting cell and each landmark also become target cells and their trajectory 
score changes. We use this trajectory score as a new orientation trajectory and repeat the 
orientation step. Since the graph itself does not change the shortest-path distances do not change 
and we can use the existing distances in the repeated trajectory score calculation. Landmark 
positions continue to change with each orientation step, which is repeated until landmark 
positions converge: 





where Li is a vector of landmark positions at orientation step i and ρ is Pearson’s correlation. 
The l-k-NNG’s trajectory is equal to the trajectory of the last orientation iteration. 
 
 
Figure 3-3. The orientation step of the Wanderlust algorithm. 
Top: the initial orientation trajectory from the early cell (s) to a target cell (t) and a landmark (l). center: the 
shortest-path distance from the landmark to the target cell. Since distance has no direction we cannot identify 
whether the target cell precedes or follows the landmark. Bottom: According to the initial orientation 
trajectory, the distance from the early cell to the target is lower than its distance to the landmark. Therefore, the 
target must be between the early cell and the landmark and we can orient the shortest-path distance from l 
accordingly.  
Finally, after a trajectory is iteratively calculated for each l-k-NGG graph, the output trajectory is 
set to the average over the trajectory scores of all l-k-NNG graphs. 
3.2.4 Pseudo-code of Wanderlust 
Input: data set of cells X = {x1, …, xn}, starting cell s, number of landmarks nl, distance function 
dist, ensemble parameters: size of ensemble ng, number of nearest neighbors k, subset size l 






 pick from X nl cells uniformly at random to serve as landmarks; set s as first landmark → 
{l1 = s, …, lnl} 
 calculate k-nearest-neighbor graph of X → G 
 randomly generate ng l-out-of-k-nearest-neighbor graphs → G1, …, Gng 
Trajectory calculation: 
 for each l-out-of-k-nearest-neighbor graph 
  calculate shortest-path distance from each landmark lj to each point xi → D = dij 
set wij to |dij|
2
 / Σk |dik|
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realign: calculate realigned distance T = tij. for each landmark lj 
 tij = dij if d1i > d1j, -dij otherwise 
 tij = tij + d1j 
set traj1,i to Σjtij/nl*wij 
repeat until convergence 
 realign tij using traj(iter-1),i 
   set trajiter,i to Σjtij/nl*wij 
  set the graph’s trajectory to traj of the last iteration 
 return average over all graph trajectories in ensemble → S 
3.2.5 Wanderlust accurately recapitulates the trajectory in synthetic data 
To evaluate Wanderlust’s performance, we first applied it to synthetic data composed of a series 
of simulated datasets. A curved, one dimensional simulated trajectory, embedded in 3-
dimensions, was generated by starting at position (1, 1, 1) and randomly traversing the space for 
10,000 steps. After each step the current position was added to the trajectory as a point. All 
datasets had the same solution trajectory (figure 3-4, top). Each dataset additionally included 
seven dimensions of normally-distributed noise. The mean of each noise dimensions was zero. 
The magnitude of each noise dimension was defined as the standard deviation divided by the 
range of the solution trajectory. Each dataset used the same magnitude for all seven noise 
channels. A total of eight datasets were generated with increasing magnitude, from zero (no 
noise) to one (noise magnitude equals the range of the solution trajectory). In total, this synthetic 
data included eight datasets, each of which had 10,000 points and ten dimensions; regardless of 





dimensions. The algorithm parameters were the same as those used in later analysis of biological 
data. 
We computed a Wanderlust trajectory for each synthetic dataset and compared the resulting 
trajectory to the solution trajectory (figure 3-4, bottom). When there was no noise, the 
algorithm’s output was almost identical to the solution (Pearson’s ρ=1). Wanderlust continued to 
faithfully recapture the trajectory as noise levels increased to magnitude as high as 0.2 (Pearson’s 
ρ=0.97). When the magnitude was increased to 0.5, output quality decreased as the entire first 
half of the trajectory was given a similar score of 0.2 by the algorithm. The second half, 
however, was well-modeled, giving a reasonable view of the system (Pearson’s ρ=0.86). As 
expected, when the magnitude reached 1, the algorithm was no longer able to detect the solution 
trajectory. Over the eight datasets, Wanderlust perfectly detected the solution trajectory in six 
datasets, reached high correlation with one dataset, and failed to detect the trajectory in the last 
dataset (where the magnitude of the noise was equal to seven times the solution trajectory). 
We next wanted to test whether Wanderlust continued to correctly detect the trajectory even 
when the data included short circuits. We chose the synthetic dataset with the lowest noise 
magnitude, 0.01 (Pearson’s ρ=0.99), as a template for the generation of sixteen short-circuit 
datasets, since we wanted to isolate the effect of the short circuits (figure 3-5a). Dataset 
generation included two parameters. The first parameter, N, was the number of short circuits 
(N=50, 100, 500, 1,000). The length of each short-circuit was randomly sampled from an 
exponential distribution whose mean, μ, was the second parameter (μ=0.01, 0.05, 0.09, 0.13). 
When μ=0.01, very few of the short circuits were long-range. However, as μ increased, short-





expected the detection quality to be inversely correlated with the number of short circuits and the 
proportion of long-range short circuits. 
The Wanderlust trajectories were well-correlated with the solution trajectory (Pearson’s ρ>0.95) 
in ten of the sixteen datasets (Figure 3-5b). As long as most of the short circuits were short-range 
(μ=0.01, 0.05) the number of short circuits (N) had only a slight effect on the algorithm’s output. 
When μ=0.09, Wanderlust detected the trajectory well until N increased to 500 (Figure 3-5b, 
third row). Even when N was equal to 500 or 1,000, the algorithm gave a reasonable solution 
(Pearson’s ρ=0.92).  
We observed an interesting inversion observed when μ=0.13 and most of the short circuits were 
long-range (Figure 3-5b, fourth row): with a small number of short circuits (N=50), Wanderlust 
modeled the first half of the trajectory well, but then backtracked and included the second half of 
the solution trajectory as a plateau, leading to a ridge in the scatter plot (Pearson’s ρ=0.59); 
however, as N increased, so did the correlation between the algorithm’s trajectory and the 
solution (Pearson’s ρ=0.74, 0.83 and 0.85 when N=100, 500 and 1,000, respectively). When 
examining the scatter plots we saw that as more short circuits were added, less of the trajectory 
was modeled well, with the rest becoming a plateau (similar to the magnitude=1 dataset in Figure 
3-4). The improved correlation is an artifact caused as the ridge in N=50 changes into noise.  
Overall, Wanderlust detected the solution trajectory in the synthetic data in almost all of the 
datasets. Despite increasing levels of noise and the incorporation of varying quantities of short 
circuits of varying lengths, the algorithm reached a high correlation with the embedded solution 
trajectory. Wanderlust’s high degree of robustness allowed it to overcome many of the 






Figure 3-4. Trajectory detection in synthetic data with increasing amounts of noise. 
Top: The synthetic datasets are composed of a 1-dimensional curve (trajectory) embedded three-dimensions 
(beginning colored in blue, end colored in red) and seven dimensions of normally distributed noise with μ=0 
and increasing magnitude (σ/range of solution trajectory; magnitude = 0, 0.01, 0.02, 0.05, 0.1, 0.2, 0.5, 1). 
Bottom: Each plot corresponds to a Wanderlust run on one of the synthetic datasets. The magnitude of the 
noise and the Pearson correlation between the solution trajectory and the Wanderlust trajectory are indicated in 
each plot’s title. The X-axes are the solution trajectory (cells are ordered by the solution) and the Y-axes are 
the Wanderlust trajectories (ordered by Wanderlust). Each dot is a cell. The Wanderlust trajectories are highly 






Figure 3-5. Wanderlust is resilient to short circuits. 
The dataset with noise magnitude = 0.01 served as the basis for 16 synthetic datasets with varying amounts of 
short circuits (top, N=50, 100, 500, 1,000). The short circuit lengths were exponentially distributed with 
increasing μ (left, μ=0.01, 0.05, 0.09, 0.13). (a) The adjacency matrix of the 30-nearest-neighbors graph of 
each N=1,000 dataset. Each point is an edge. The X- and Y-axes are node numbers, ordered by the solution 
trajectory. The diagonal is composed of the real neighbors while the surrounding cloud is the short circuits. As 
μ increases the short circuits connect points which are more distant across the solution trajectory. (b) 
Wanderlust runs on these synthetic datasets. The X-axes are the solution trajectory and the Y-axes are the 
Wanderlust trajectories. Pearson’s correlation values are given at each plot’s title. As the number of short 
circuits increases, Wanderlust remains well correlated with the solution trajectory unless too many short 







Chapter 4 Trajectory detection orders hallmarks 
of early human B cell development 
4.1 Introduction 
B lymphocytes, whose central role is producing immunoglobulin, are a crucial component in the 
body’s adaptive immune system. [1, 87]. An immunoglobulin, or antibody, is a Y-shaped protein 
that can bind to foreign objects (such as pathogens) and either neutralize them outright or assist 
other parts of the immune system in identifying them. The antibody is composed of two regions: 
the variable (V) region and the constant (C) region. The V region, which includes the antigen-
binding site, defines the target of the antibody. Its sequence is generated during B cell 
development through a random process of genetic recombination. The C region, also referred to 
as the antibody isotype or class, defines the effector function of the antibody, including its 
distribution in the body and its functional activity. 
The early development of B cells in humans, mice, and most other mammals occurs in the bone 
marrow. The immune cells pass through a series of stages: a hematopoietic stem cell, followed 
by a progenitor cell, a pro-B cell, a pre-B cell, and finally an immature B cell, which migrates 
out of the marrow [88-90]. Immature B cells then circulate between the various peripheral 
lymphoid tissues (such as the white pulp of the spleen or the lymph nodes) until they settle into 
either B-cell regions called follicles (in which case they are called follicular B cells) or the 
marginal zone of the spleen (in which case they are called marginal zone B cells) [91]. Follicular 
B cells are activated by a combination of antigens and signals from T helper cells and then 





tailored to the target antigen (a process called somatic hypermutation), and their antibody’s C 
region might change to a different isotype (class switching). The cells can later differentiate into 
plasma cells, terminally differentiated cells whose purpose is the production of large amounts of 
antibody, or into memory B cells, slowly-dividing cells that can be used against later encounters 
with the same foreign object. Marginal zone B cells are resting, mature cells which are recruited 
to the early adaptive immune response in a T cell independent manner in response to specific 
types of extracellular bacterial pathogens.  
The formation of a productive immunoglobulin is achieved through the genetic recombination of 
different V, D and J gene segments [92, 93]. First the heavy chain locus of the immunoglobulin 
(IgH) is rearranged during the pro-B cell stage: one D and one J segment are recombined by 
deleting the DNA between them followed by the joining of one V segment (again by deleting the 
DNA between the D and the V segments) [94, 95]. Likewise the V and J segments of the light 
chain loci are combined during the pre-B cell stage [93]. The recombination process is well-
regulated through multiple mechanisms, including transcription, signaling, and cell proliferation 
and apoptosis [96-102]. Because of  their fairly linear differentiation path and localization to the 
bone marrow as the primary site of development, B cells provide an interesting model for 
studying development of cells. 
Different B cell stages can be identified through the expression of certain cell surface proteins, 
such as CD34 in stem cells and CD20 in more mature B cells [59, 89]. Much of the current 
understanding of human B cell development is based on studies using murine models, which 
allow large numbers of cells to be analyzed but are limited due to their intrinsic differences from 
human B cell development [101, 103]. Current state-of-the-art cytometry technology utilizes 





ability to examine multiple cell stages within a single sample. To bridge these gaps, we utilized 
mass cytometry in order to measure the expression level of more than 30 proteins in hundreds of 
thousands of B lineage cells in primary human bone marrow from healthy donors [12, 14]. 
However, this approach led to two computational challenges. First, the data were composed of a 
high number of nonlinearly correlated dimensions. Second, both the biological system and the 
technology itself were sources of noise that obscured the true developmental signal. A 
computational method for the exploration of B cell development using mass cytometry was 
needed to consider these statistical properties of the data. 
As discussed above, we developed Wanderlust, a graph-based trajectory detection algorithm. 
Wanderlust’s input is measurements of all cells in a system during a single time-point. The 
algorithm then identifies the trajectory underlying the system: that is, the developmental ordering 
of the cells. Wanderlust does not make any assumptions regarding the distribution of the data and 
is resistant to noise. It is composed of two steps: an initialization step, where the data is 
transformed into an ensemble of graphs, and a trajectory calculation step, where shortest-path 
distances are used to iteratively refine the trajectory for each graph. The average over the 
trajectories of all graphs is returned as the final trajectory score- the position of each cell across 
the developmental trajectory.  
We showed that the Wanderlust trajectory is an accurate depiction of B-cell development. 
Furthermore, the use of the Wanderlust trajectory aided in the identification of novel population 
of early B cells. Coupling the Wanderlust algorithm with high dimensional mass cytometry data 
allowed the observation of the timing of developmental checkpoints and the coordination of 





powerful algorithm for the identification of an underlying time element in a static snapshot of a 
dynamic system. 
4.2 Results 
4.2.1 Wanderlust captures the features of B-cell lymphopoiesis 
Given Wanderlust’s performance on synthetic data, we investigated its effectiveness in the 
analysis of a complex tissue by applying it to a cohort of primary human marrow aspirates and 
focusing on the development of the B-cell lineage. Bone marrow B lymphopoiesis, being a non-
branching process with all involved cells present in a single tissue, represented an ideal real-
world test case for the algorithm. 
Each acquired healthy bone marrow sample was enriched for B-lineage cells via magnetic bead 
depletion, where several non-B-lineage cell subtypes were removed: red blood cells, myeloid 
cells and T cells. The mass cytometry panel included cell surface markers (CD45, CD19, CD22, 
IgD, CD79b, CD20, CD34, CD179a, CD72, IgM-i, Kappa, CD10, Lambda, CD179b, CD49d, 
CD24, CD127, CD38, CD40, CD117, HLADR and IgM-s), signaling markers (cPARP, pPLCg, 
pSrc, pSTAT5, pAKT, pSyk, pErk12, pP38, pCreb), cell cycle markers (Ki67, pCreb), and TdT 
and Rag1, two enzymes which are responsible for the genomic rearrangement in B cells. An 
additional post-acquisition computational enrichment stage which was based on cell length and 
DNA content removed debris, doublet events, and dividing cells. Any remaining non-B-lineage 
cells were removed using a dump channel that included canonical markers for several non-B-
lineage cell subtypes (CD3, CD235, CD61, CD66b, CD33, CD11c, CD16). After these cleaning 





To evaluate the Wanderlust trajectory, we applied the algorithm to the 21 phenotypic markers in 
each sample. The list of input markers and Wanderlust parameter values, including the distance 
metric used, are given in the Materials and Methods section. We visualized marker expression 
trends across the trajectory by calculating the trace of each marker over the trajectory using a 
sliding window. The trajectory was first divided into one hundred overlapping, equidistant 
windows. The width of each window was 8% of the total trajectory width (window widths 
between 6% and 12% were tested and provide comparable results). For each marker, the median 
marker intensity was calculated in each window (Figure 4-1a). In addition, the trajectory was 
divided into ten non-overlapping windows. In each of these windows, we examined the biaxial 
plot of three surface marker pairs: CD34 versus CD38, CD19 versus CD10 and CD20 versus 
surface IgM (figure 4-1b). This second visualization using biaxial plots followed the established 
view of B-cell development and serves as support for the Wanderlust trace. 
To anchor the trajectory to known early B-cell development we examined markers whose levels 
are well-characterized (Figure 4-1). Wanderlust faithfully captured known trends across the 
progression [31, 47-49]: CD34 is the earliest marker expressed and is rapidly followed by CD38 
expression, as demonstrated by both the Wanderlust trace and in the biaxial plots. CD10 
expression is next. Shortly after CD19 levels begin to increase. As CD34 levels decline, IgH 
rises on the surface of the more mature cells that have productively rearranged the heavy chain 
locus of the immunoglobulin gene. CD20 expression rises in concert with a decrease in CD10 
and the expression of the kappa light chain. Kappa expression rises and peaks and is followed by 
the expression of lambda, the alternative light chain component. In addition to recapitulating 
known trends, the trajectory serves as a quantitative scaffold that clarifies the relative timing and 





peaks while CD34 decreases, and that CD19 plateaus when IgM reaches half of its maximum 
intensity. The trajectory is a continuous estimate of marker expression levels in relation to each 
other. 
 
Figure 4-1. Wanderlust detects the trajectory of B-cell development. 
The Wanderlust algorithm applied to B-lineage cell data from a healthy human bone marrow sample. (a) The 
traces of well-characterized developmental markers. The X-axis is the trajectory, divided into 100 overlapping, 
equidistant windows. Y-axis is the median normalized marker intensity in each window. Marker expression 
levels follow known trends. (b) Biaxial plots of CD34 versus CD38, CD19 versus CD10 and CD20 versus 
surface IgM in ten discrete windows across the trajectory. The red arrows show the expression changes from 
the previous window. Expression levels shift according to known trends as development progresses. 
The variation in the expression of each phenotypic marker as a function of the Wanderlust 





epitopes was relatively low, indicating their combined concordance in the model and the ability 
of the algorithm to leverage multi-dimensional information to create a highly organized 
trajectory of cellular development. This tightness was especially apparent with TdT, which was 
not used as input to the algorithm. Additionally, examining variability across the trace reveals 
whether changes in marker expression are gradual (for example, CD38 and CD24) are more 
threshold-like in nature (such as the decrease in CD34 or the increase in IgM). The low 






Figure 4-2. The marker expression distribution across the trace over the trajectory is tight. 
Each panel corresponds to one marker (given at the title). The trajectory has been divided into 100 overlapping 
windows. In each window, the distribution of each marker has been calculated using a kernel-density 
estimator. X-axis is the trajectory, Y-axis is the density estimation at each window. Red denotes the highest 






4.2.2 Wanderlust is robust over multiple runs and different samples 
The Wanderlust algorithm initialization includes two stages that require random choices: the l-k-
NNG ensemble generation (choosing of l out of the k-nearest neighbors for each node) and the 
landmark selection. These random processes could influence the output trajectory and lead to 
different results. To evaluate the robustness of the algorithm and reject this possibility, we re-ran 
the Wanderlust algorithm five times using the same healthy bone marrow sample data. The five 
runs were executed independently and each started from a different seed for the random number 
generator. The cell orderings over the five runs were almost identical (figure 4-3) with Pearson 
correlation greater than 0.99. While the second half of the trajectory seems to have more 
variation between pairs of runs, this was a visual artifact caused by the higher number of cells in 
that region of the trajectory (which was composed of more mature cells). In summary, 
Wanderlust is a robust algorithm that provides a consistent trajectory over multiple runs on the 
data. 
Next, we wanted to verify that the Wanderlust trajectory is consistent over multiple individuals, 
thus representing human B-cell development, rather than that of a specific individual. We 
applied the algorithm to data from four healthy bone marrow samples that were acquired from 
different healthy individuals. However, a direct comparison between the trajectories is 
misleading. If a sample includes many cells of a given subtype, these cells will occupy a larger 
region of the Wanderlust output than other, less-represented subtypes. When examining multiple 
bone marrow samples, the proportions of different cell subtypes vary according to many factors 
(such as genetics, exposure to pathogens, and others). The altered proportions will lead to scaling 





populated areas expand. Therefore, the ordering provided by the trajectory is relative within the 
sample and cannot be applied to other samples.  
We addressed this issue using the mean of all marker cross-correlations. Given a marker, for 
each sample we calculated the cross-correlation between that marker’s trace in the sample and its 
trace in an arbitrarily chosen base sample. The trajectory was shifted such that the mean of all 
cross-correlations was maximized (figure 4-4). We next examined the cross-correlation corrected 
traces of several markers across the four trajectories. Even after shifting by the aggregate cross-
correlation, the mean Pearson’s correlation between the marker traces over the four samples 
remained high (ρ > 0.9 for all markers). The traces for TdT, which was not used in the 
Wanderlust analysis, were especially correlated (ρ = 0.94). Apart from that, no one marker 
seemed to be better coordinated across the samples. Likewise, no members of sample pairs 
seemed to be better correlated with each other: for example, while the IgM and TdT traces for 
samples b and c neatly overlap, their CD24 and IgD traces are dissimilar. Combining figures 4-3 







Figure 4-3. Wanderlust outputs a consistent trajectory over multiple runs and different samples. 
Repeated Wanderlust runs for the same sample, using different random seeds. The X-axes and the Y-axes are 
the algorithm’s output for the respective runs. Pearson’s correlation is given in each plot’s title. The correlation 






Figure 4-4. Wanderlust outputs a consistent trajectory over different samples. 
Marker traces across the Wanderlust trajectory for 4 different healthy human bone marrow samples (denoted a 
to d). The trajectories were aligned using cross-correlation. The traces are almost identical between the 
samples (Pearson’s ρ never drops below 0.9).). 
4.2.3 Wanderlust is robust over a wide range of parameter choices 
Wanderlust requires the user to supply several parameters along with the input data. Key among 
these is the early cell that serves as the start of the initial orientation trajectory. However, 
locating an absolute starting point for B-cell development or other biological processes is 
challenging. First, the definition of the starting cell might be inaccurate or unavailable; for 
example, only a subset of the stem-cell markers might be known. Noise in the data might result 
in a later cell having higher values in the relevant markers, obscuring the true starting cell. 
Alternatively, the measured panel might not even include the markers needed due to technical 









 stem cell. This is an approximate starting cell and the data might have other cells 
preceding it in the developmental chronology. 
We used the output from the Wanderlust run described in figure 4-1 as a baseline trajectory for 
testing the influence of the early-cell parameter on the algorithm’s output. We re-ran Wanderlust 
ten times. Each time, the early cell (s) was shifted by 0.1 across the baseline trajectory and the 
output was compared to our initial run (figure 4-5). As long as s remained within the first third of 
the baseline trajectory the two trajectories overlapped (Pearson’s ρ=0.99, 0.99 and 0.98 for 
s=0.1, 0.2 and 0.3, respectively). When s is set to the midsection of the baseline trajectory (s=0.4, 
0.5, 0.6 or 0.7), we see that Wanderlust breaks the output trajectory in half: the algorithm models 
the second half of the trajectory well, then backtracks and models the second half in reverse. The 
latest cells are connected to the earliest cells, with the middle becoming a starting point. Finally, 
when s is a later cell (s=0.8, 0.9, 1.0), Wanderlust detects the reverse trajectory, starting from the 
latest cells and going back to the earliest cells (Pearon’s ρ=-0.98, -0.96 and -0.95, respectively). 
The algorithm has a meaningful output for a wide range of early cell choices, and only an 
approximate early cell is needed to detect the trajectory. Moreover, Wanderlust can recover an 
accurate reverse trajectory when starting from a late cell and going towards an early cell. 
The generation of the l-k-NNG ensemble involves two parameters: k, the number of nearest 
neighbors in the initial k-NNG, and l, the neighbor subset size for each node in each graph. 
These parameters have several ramifications on the algorithm’s performance. If k is too low, the 
k-NNG might be disconnected. Likewise, if l is too low, too many edges will be removed and the 
l-k-NNG will not be connected. In both cases some of the cells will be unreachable by the graph 
walk and will not be ordered at all by the algorithm. On the other hand, a high k will increase the 





overlap across the l-k-NNG ensemble. From a complexity perspective, increasing l reduces the 
sparsity factor of the graph, leading to slower run times. In light of the above, k/l choice is 
crucial for accurate results. 
All prior Wanderlust runs used the values k=30 and l=5 (each cell had 30 neighbors in the initial 
k-NNG, 5 of which were chosen in each l-k-NNG in the ensemble). We tested all combinations 
of k and l values over a set of values (k=20, 30, 50, 100, l=5, 10, 20, 30). The Wanderlust 
trajectory generated in figure 4-1 was again used as the comparison baseline. The correlation 
between the figure 4-1 trajectory and each k/l combination trajectory was high (figure 4-6, 
Pearson’s ρ greater than 0.99), showing that the algorithm is generally consistent over choices of 
these two parameters. However, when examining the scatter plot for k=20, l=20 (figure 4-6, 
bottom left), we see the effect of a short circuit: a cloud of cells diverges from the baseline 
toward the end of the trajectory, showing that that region is not modeled well. Since l was 
identical to k, there is no l-k-NNG ensemble and the algorithm is susceptible to this short circuit. 






Figure 4-5. Wanderlust is robust to early-cell parameter choice. 
The Wanderlust algorithm has been rerun ten times with the early-cell parameter advancing across the baseline 
trajectory from figure 4-1. X-axes are baseline trajectory, Y-axes are Wanderlust’s output for given s. Each dot 
is a cell along the trajectory. Pearson’s correlation and “starting point” location is given in title. The 
Wanderlust trajectory is well correlated with the baseline for s=0.1, 0.2 and 0.3, and is inversely correlated (the 
algorithm detects the reverse trajectory) for s=0.8, 0.9 and 1.0. For other values of s, Wanderlust broke the 






Figure 4-6. Wanderlust is robust to k/l parameter choice. 
The Wanderlust algorithm has been rerun twelve times with different k/l parameter values. The figure 4-1 
trajectory used k=30 and l=5 as parameters (top row, second from left). X-axes are the baseline trajectory, Y-
axes are the output trajectory for the k/l parameter choices denoted above and to the left. Pearson’s correlation 
values are given in the titles. The correlation is greater than 0.99 for all parameter combinations. A short-
circuit can be seen when k=20, l=20 (bottom left plot). 
The last set of parameters is Ng, the number of graphs in the l-k-NNG ensemble, and Nl, the 
number of landmarks. The number of graphs is again tied to Wanderlust’s resistance to short 
circuits: a certain minimum number of graphs are needed or a short circuit might randomly 
appear in enough of them to skew the output trajectory. The number of landmarks is related to 
the algorithm’s ability to reduce the variability caused by using the shortest-path distance. Since 
short distances are more reliable than long distances, enough landmarks are needed to guarantee 





to increasing Ng and Nl, as there is no threshold above which these parameters will diminish the 
quality of the output trajectory. For purposes of optimizing runtime, however, there can be a 
downside to increasing Ng and Nl, because both  are factors in Wanderlust’s complexity. 
To evaluate robustness, we tested multiple values for Ng and Nl (figure 4-7). The rest of the 
parameters were identical to the run in figure 4-1, which was used as the baseline, and in which 
Ng=20 and Nl=20. When Ng=1, Wanderlust performs poorly irrespectively of the number of 
landmarks utilized (figure 4-7, left). The algorithm follows the set of short circuits randomly 
chosen in that l-k-NNG, leading to a distorted view of the second half of the trajectory. The 
layered structure of the scatter plot allows us to follow the number of short circuits in each graph 
(for example, for Ng=1, Nl=5, there are seven short circuits in the graph). The trajectory 
improves when Ng=10, although the variability of its second half is very high when Nl=5. This 
trend of high noise between later cells continues as long as Nl=5, irrespective of Ng. Finally, 
when using at least ten graphs and at least twenty landmarks, Wanderlust outputs a consistent, 
high-quality trajectory, marking these values as the threshold for robust trajectory detection in 







Figure 4-7. Wanderlust is robust to Ng/Nl parameter values past a certain threshold. 
Wanderlust has been rerun a dozen times with different Ng/Nl parameter values. The comparison baseline is 
the trajectory from figure 4-1 (where Ng=20, Nl=20). X-axes are the baseline trajectory and Y-axes are the 
Wanderlust trajectory for that Ng/Nl parameter combination. Pearson’s correlation values are given in the title. 
The algorithm fails the model the trajectory when Ng=1. The second half of the trajectory has high variation 
when Nl=5. In all other cases Wanderlust outputs a faithful representation of the trajectory. 
4.2.4 Wanderlust is robust to marker selection 
Marker selection is a central part of experiment design. Canonical markers are considered crucial 
in the identification of certain cell stages. Additionally, while mass cytometry offers a substantial 
increase in panel size, we cannot comprehensively include all of the surface markers that are 
expressed by the variety of immune system cell types, or even by just B-lineage cells. Since 
Wanderlust is only given a subset of possible markers, this raises the possibility that a missing 





To test the robustness of the trajectory to our selection of phenotypic features we independently 
ran Wanderlust multiple times. Each time, we removed one marker and calculated both marker 
traces and the correlation between the Wanderlust output and the original trajectory (Figure 4-8). 
Exclusion of any one individual maker had little effect on the results of the overall trajectory as 
evidenced by the strong correlation with the original model (Pearson’s ρ > 0.97). Qualitatively, 
marker traces are identical between the different runs and faithfully follow the continuum of B-
cell development. The only exception is HLA-DR, a component of all antigen-presenting cells, 
which had the greatest influence on the algorithm output with its exclusion dropping the 
correlation to 0.796. Notably, HLA-DR did not appear to affect the relative ordering of B-cell 
stages, only their position across the Wanderlust trajectory, suggesting it has a role in 
partitioning unrelated cell-types. Overall, for the representative Wanderlust trajectory discussed 






Figure 4-8. Wanderlust does not rely on any individual marker. 
(a) Resulting Wanderlust trajectories from leave one out testing in which CD19, CD45, CD10, CD34 and 
HLA-DR were omitted from the trajectory algorithm. (b) Correlation to original trajectory (Figure 4-1) when 
indicated marker is omitted from the construction of the trajectory. Omission of HLA-DR (red box) in the 






4.2.5 Wanderlust uncovers and orders emerging B cell precursors 
Following the robustness analysis, we used the Wanderlust trajectory to guide the identification 
of distinct, early populations and determine their relative ordering in developmental time. Due to 
TdT’s role in the earliest activities known to define mammalian B cell emergence, we 
hypothesized that its combination with CD24 and other progenitor markers could serve as a 
novel set of identifiers to dissect early fractions of human B cells emerging in the marrow. We 
used Wanderlust to guide a series of biaxial gates based on CD34, CD38, CD24 and TdT, so that 
the resulting fractions best match Wanderlust’s order of these cells (Figure 4-9a, left). Drilling 




 fraction using the combined expression C24 and TdT revealed four 
distinct populations of cells. According to Wanderlust, these were early cellular fractions that 
sequentially occupy populations II-V, beginning with TdT expression, followed by cell surface 
expression of CD24 and finally loss of TdT as they proceed through development. 
Enabled by the dimensionality of our single cell data, the expression of additional phenotypic 
markers could be used to support the progression of these populations and their identity as 
definitive early B cells. Intracellular λ5 (CD179b), a component of the surrogate light chain 
(sLC) of the pre B cell receptor (pre-BCR), is expressed first within population II (Figure 4-9b). 
As cells progressed to population III, the expression of CD10 emerges. By the time cells reach 
population IV, almost all co-express sLC proteins which coincides with maximal expression of 
CD10, aligning these cells with the pro B cell stage of development. Finally, as cells reach 
population V, most cells have lost Vpre-B, λ5, CD10 and all express the IgH protein intra-
cellularly as they enter the later stages of Pre-B cell development (Figure 4-9b). Consequently, 
the Wanderlust trajectory of these populations (II-V) is confirmed by the co-expression patterns 






Figure 4-9. Wanderlust uncovers rare B cell progenitors prior to the expression of CD10 or CD19. 
(a) Wanderlust trace demonstrating CD24 expression rising sharply following the expression of CD34, CD38, 
and TdT (upper left panel). Examining the expression of TdT and CD24 on the CD34+CD38+ fraction on a 
contour plot demonstrates four easily gatable populations. An overlay of the median Wanderlust values for the 
cells contained within these gates (dark blue gates, labeled as population I-V), reveals the progression in 
maturity from cells in Fraction I (median WL 0.12) to Fraction II (median WL 0.2) to Fraction III (median WL 
0.22) to Fraction IV (median WL 0.31) to and Fraction V (median WL value 0.5). (b) Expression of additional 
early B cell markers supports the B cell identity of these fractions. Once in population II, expression of λ5 rises 
on a minority of cells and by population IV, 100% of cells co-express both components of the surrogate light 
chain of the pre-B cell receptor, λ5 and Vpre-B. By population V, about half of cells have downregulated 
expression of these proteins. CD10 expression rises as cells transit population III-IV and by the time cells 
reach population V, the majority express intracellular immunoglobulin heavy chain (IgHi). (c) Results of 
relative amount of IgH DJ rearrangement as determined by qPCR analysis of genomic DNA from 
prospectively isolated cells from populations II-IV. Results are representative of two biological replicates and 
normalized to population II. (d) Results of relative amount of IgH DJ rearrangement as determined by qPCR 
analysis of genomic DNA from prospectively isolated cells from populations II-IV. Results are representative 
of two biological replicates and normalized to population II. (e) Grey pie chart displays the relative fractions of 
cell types contained in ficolled mononuclear cells from human bone marrow. Red slice demarcates 
CD34+CD38+ fraction. Purple pie chart displays the percentage of cells in populations II-IV that are contained 





4.2.6 VDJ Recombination confirms Wanderlust’s ordering of novel early human B cell 
populations 
We sought to further confirm the Wanderlust trajectory by examining the rearrangement of the 
germline IgH locus, which is the target of TdT and a measure of B cell identity. We developed a 
quantitative polymerase chain reaction (qPCR) assay that could linearly quantify the relative 
proportions of DJ- and VDJ-arranged cells in a mixed population. We used fluorescence 
activated cell sorting to isolate populations II-V from healthy bone marrow preparations from 
two individuals, extracted genomic DNA from each fraction and determined IgH rearrangement 
status using the qPCR assay.  
We found progressive rearrangement of the IgH locus from population II to population V. The 
majority of cells had detectable DJ rearrangement by the time they reached population IV and 
completed VDJ rearrangement upon reaching population V (Figure 4-9c, d). This was consistent 
with the observation that virtually all cells in fraction V displayed intracellular expression of IgH 
protein (Figure 4-9b, asterisk). Thus, by establishing the progressive rearrangement of IgH in 
these populations, we confirmed that the Wanderlust trajectory not only facilitated the 
characterization of the earliest human B lymphocytes, but also accurately ordered their correct 
developmental timing, all from the analysis of a single human marrow, without synchronization 
or manipulation. 
The ability to both identify and order emerging human B-lymphocytes across numerous 
individuals was particularly notable given their sparsity. Figure 3E highlights the rarity of these 
early B-cell fractions relative to the whole bone marrow. In particular, fraction III comprised 
only 0.007% of the mononuclear cell fraction of whole bone marrow. The fact that fraction III 





CD10 (Figure 4-9b) offers an explanation as to why these fractions have not been described 
previously, phenotypically or functionally.   
4.2.7 Wanderlust reveals pSTAT5 response to IL-7 is confined to rare B cell precursors 
We sought to further characterize these early B-cell precursors, whose role in human B 
lymphopoiesis had been elusive to date. Mass cytometry allowed us to simultaneously measure 
not only surface markers, but also internal functional proteins and their modifications in the same 
cells. To functionally characterize early B cells and how these respond to stimuli, we collected 
data following perturbation with the cytokine IL-7. We focused on the activation of STAT5 by 
IL-7 via its phosphorylation site due to its critical regulatory role in mouse lymphopoiesis [104-
107]. In mice, disruption of this pathway results in arrest of B cell maturation at the pro-B cell 
stage [98]. However, in the human, the precise developmental timing of this pathway and its 
regulatory role remain unclear.   
Investigation of signaling response to IL-7 across the four early B cell populations II-V revealed 
that cells within population III displayed an almost exclusive induction of STAT5 
phosphorylation (Figure 4-10a) – a striking observation considering population III represents less 
than one in ten thousand cells in the marrow. Moreover, this pinpointed response was consistent 
across seven individual marrows. We note that pSTAT5 and other functional markers were not 
used to construct the Wanderlust trajectory and therefore this pattern of pSTAT5 induction was 







Figure 4-10. Regulatory signaling re-wires across development. 
(a) Compared to basal control, IL-7 induces maximal induction of pSTAT5 in population III 
(CD34+CD38+TdT+) consistently across seven individual biologic replicate human bone marrow samples. (b) 
Population III and population IV can also respond to thymic stromal lymphoprotein (TSLP) by induction of 
pSTAT5. Jak 1/3 inhibitor, tofacitinib, abrogates some IL-7-induced pSTAT5 signal in population III but has 
no effect on other developmental fractions. (c) Across the early half of the Wanderlust trajectory (0-0.5) 
expression of the IL-7rα rises early along with TdT but prior to expression of IgHi. Heatbar indicates basal 
pSTAT5 expression levels across early trajectory. Developmental timing of populations I-V is indicated at the 
top of the trace along with timing of IgH loci rearrangement. (d) Overlying the timing of populations III and 
IV demonstrates a switch of the regulatory network such that cells occupying population III demonstrate a Jak-
dependent induction of pSTAT5 in response to IL-7 exposure whereas when cells transition to occupy 
population IV they are no longer responsive to IL-7 but maintain high basal pSTAT5 levels suggesting 
inhibition of a negative regulator or an alternative route of stimulation.   
4.2.8 Wanderlust captures STAT5 network rewiring 
Since the IL-7/STAT5 response was limited to a specific fraction, we sought to further 
characterize STAT5 regulation, relative to adjacent fractions. Activation of pSTAT5 by 
phosphorylation in mature lymphocytes is mediated by Janus kinase [108]. To confirm a Janus 





combined with IL-7 stimulation. As expected, within population III, STAT5 activation could be 
attenuated by treatment with Tofacitinib, but not the SRC inhibitor Dasatinib, indicating a JAK 
mediated mechanism in these cells (Figure 4-10b).  
Populations III’s induction of pSTAT5 coincides with the cells gaining expression of the IL-7 
receptor (CD127), where all CD127 positive cells strongly induce pSTAT5 in response to IL-7, 
explaining the lack of induction in earlier populations. IL-7 receptor levels do not peak at 
population III, but rather continue to rise in populations IV and V (Figure 4-10c, red line), yet ex 
vivo IL-7 stimulation no longer induces pSTAT5 in these later populations. Following the 
induction of pSTAT5 by IL-7 in population III, subsequent cells occupying fraction IV display a 
higher basal level of pSTAT5 (Figure 4-10c, bottom yellow bar). To test if pSTAT5 levels are 
saturated in later fractions, we used the pan tyrosine phosphatase inhibitor pervanadate (PVO). In 
the presence of PVO, the levels of pSTAT5 rose in all CD34+ progenitor B cell fractions, across 
biological replicates (Figure 4-10b). Additionally, cells in fractions III and IV yielded a similar 
STAT5 phosphorylation pattern in response to a thymic stromal lymphoprotein (TSLP) (Figure 
4-10b), a ligand that shares the IL-7rα chain and is known to activate STAT5 [105].  
Therefore, though STAT5 activation by IL-7 was restricted to the cells of population III, it was 
neither due to the lack of IL-7 receptor on later cell fractions, nor to their lack of STAT5 
expression or ability to phosphorylate it. Together these observations illustrate a STAT5 network 
rewiring over the development of B cell precursors (Figure 4-10d). First, STAT5 
phosphorylation is initially dependent upon IL-7 in a JAK mediated mechanism (population III). 
Then, despite continued expression of the IL-7 receptor, STAT5 phosphorylation becomes 






4.2.9 STAT5 network rewiring occurs during immunoglobulin rearrangement 
Previous studies in mouse have implicated the IL-7-dependent STAT5 induction in both the 
initiation of IgH rearrangement and the suppression of the kappa (light chain) locus [98, 109]. 
Using the trajectory as a scaffold, we could overlay the different measured elements and examine 
their relative timing. The peak expression of TdT (Figure 4-10c) indicates that cells in population 
IV are actively rearranging the IgH locus of the immunoglobulin gene, which is further 
supported by our qPCR assessment of IgH loci rearrangement (Figure 4-9c-d).  
Thus, the switch in regulation of STAT5 activation overlaps with the cell undergoing genomic 
rearrangement. An IL-7-dependent stage of STAT5 activation at population III as IgH loci 
rearrangement is initiated, followed by an IL-7-independent stage during germline gene 
rearrangement (a perilous cell state that requires careful regulation). Following completion of 
IgH rearrangement, expression of the IgH protein rapidly rises in cells transitioning into 
population V (Figure 4-10c, blue line). Thus, when cells are analyzed by Wanderlust, we can 
observe coordinated rewiring of the regulatory signaling network across these rare, early B cell 
populations (Figure 4-10d).  
4.2.10 Derivative analysis of Wanderlust reveals coordination points in development 
The coordinated expression of phenotypic markers coupled with re-wiring of regulatory 
signaling implied that these events coalesced around developmental checkpoints controlling the 
progression of B-cell lymphopoiesis. This highly multiplexed dataset combined with the 
developmental ordering revealed by Wanderlust allowed us to examine the concurrent timing of 
protein expression across B-cell development. By approximating each parameter’s derivative 
along the Wanderlust trajectory, we were able to quantify the rise and fall in their expression  





across the trajectory, we uncovered ‘coordination points’, when the change in expression of 
multiple proteins coalesce across B cell development (Figure 4-11b). 
 
Figure 4-11. Coordination of protein expression across B cell development. 
(a) The first derivative was calculated for the windows across each marker’s trace. These values are expressed 
as a heatmap with red indicating a positive slope (increasing expression) and blue indicating a negative slope 
(decreasing expression). (b) Results of the first derivative analysis. Markers were hierarchically clustered. (c) 
Coordination point (red dashed line and box) at approximately 0.25 Wanderlust with rise in Vpre-B, λ5, TdT, 
CD10, and CD24 and fall in CD117. (d) Coordination point between 0.3 and 0.4 (blue dashed line and box) 
with drop in CD34 expression and rise in CD19, CD20, IgHi, and Pax5. (e) Coordination point at 0.6 (purple 
dashed line and box) showing the rise in CD20 with rise in kappa light chain protein. Lambda light chain 
expression rises later.  Asterisks call out decline in kappa light chain expression co-incident with rise in 
lambda light chain. (f) Coordination point (black dashed line and box) at 0.8 with drop in CD38 expression, 
rise in CD40, IgD and CD22 expression. 
At least four major inflection points of coordinated epitope expression can be identified across 
the trajectory (Figure 4-11b, dashed boxes). The first occurs between 0.2 and 0.3 (Figure 4-11b, 
red box) with the induction in expression of TdT, CD10, Vpre-B (CD179a), λ5 (CD179b) and 





line). This coincides with fraction III, the IL-7-dependent pSTAT5 cells (Figure 4-10), the 
overall combination of markers represents cells at the early pro-B cell stage of development 
[110] and occurs just prior to the timimg of IgH locus rearrangement. In the next coordination 
point, CD45, CD72, CD19, and Pax5 rise in concert with intracellular expression of IgH 
(essentially intracellular heavy chain IgM) while CD34, TdT, Vpre-B, and λ5 expression fall 
(Figure 4-11b and d, blue box and line). This combination of marker flux is consistent with cells 
that are passing through the pre-B cell stage and are preparing to rearrange the light chain locus 
of the immunoglobulin. 
Light chain rearrangement is at the center of the latter two coordination points. The first of these 
(Figure 4-11b, purple box) coincides with kappa light chain protein expression, which mirrors 
the trajectory of CD20, signifying that the expression of CD20 occurs in concert with BCR light 
chain rearrangement and expression (Figure 4-11e, purple line). Cells that do not successfully 
express kappa switch to lambda light chain, which is both consistent with the known biology and 
correctly ordered by Wanderlust in this example (Figure 4-11b, asterisks and Figure 4-11e). 
Lastly, the synchronized induction of CD40, CD22, IgD expression coupled with the loss of 
CD38 expression (Figure 4-11b and f, black box & line) cements the emerging cells as naïve, 
immature B cells preparing to enter peripheral lymphoid organs [110].  
In summary, Wanderlust successfully analyzed a dynamically asynchronous cellular system 
providing a holistic picture of the coordination of a complex system, even for the most transient 
and rare cell types. Such fine timing of both regulatory and cellular events suggest these 





4.2.11 Coordination points predict a checkpoint for B-cell developmental progression 
Coordinated aspects of cell cycle and programmed cell death come into play throughout tissue 
homeostasis, to guide the transition through developmental checkpoints, as well as to control the 
size of each cellular compartment in a given tissue. Using Wanderlust to overlay simultaneously 
measured indicators of cell proliferation (Ki67) and apoptosis (cleaved poly ADP ribose 
polymerase– cPARP) revealed yet another level of functional coordination across these nascent 
human B cell fractions (Figure 4-12a). Just prior to the first inflection point (Figure 4-12a, red 
arrow), the cells are characterized by IL-7 dependent activation of STAT5 phosphorylation 
(Figure 4-10). Remarkably, this coordination point marks a transition from a state of high to low 
proliferation, as assessed by decreasing Ki67 expression (Figure 4-12a, background shade). This 
drop in proliferation leads directly into fraction IV where Vpre-B and λ5 rise (Figure 4-12a), 
signifying the transition into pro-B cells, where IgH gene locus rearrangement activity has been 
established (Figure 4-9c-d). While this pro-B cell checkpoint has never been clearly 
demonstrated in the human, we see it here for the first time as the cells transition between 






Figure 4-12. Regulatory signaling influences cell fate decisions in developing B cells. 
Wanderlust traces for Vpre-B, λ5 and IgHi across the early trajectory. Background of plot shaded by heatbar 
indicating Ki67 (proliferative antigen) levels. Alignment of populations II-V across early trajectory indicates 
high Ki67 levels in population III just prior to Vpre-B and λ5 expression followed by quiescence during IgH 
rearrangement in population IV. Immediately prior to IgHi expression a spike in cleaved PARP (yellow line) 
occurs. This is followed by another burst of Ki67 expression. Red arrow indicates putative timing of pro-B cell 
coordination point. Blue arrow indicates putative timing of pre-B cell coordination point. (b) Wanderlust trace 
of the late trajectory showing IgH expression intracellularly (blue line) followed by IgH expression on the cell 
surface (green line). Basal levels of pPLCg2, a downstream marker of B cell receptor signaling is indicated in 
black. In response to cross linking of the B cell receptor, pPLCg2 is induced to the level of the red line and the 
fold change induction is shown in yellow. (c) Primary B cell co-culture was performed using two individual 
human bone marrows following lineage depletion cultured for 6 weeks on an OP-9 stromal layer in the 
presence or absence of inhibitors. Cells were analyzed by flow cytometry after the completion of the six-week 
culture period. (d) Frequency of cells occupying populations II-IV after six weeks of culture in the presence of 
DMSO control or targeted kinase inhibitors (SB203580-pP38i, Ruxolitinib-JAK1/2i, Tofacitinib-JAK1/3i). 
Treatment with Ruxolitinib results in increased cells occupying population II (p<0.01) and less cells occupying 
population IV (p<0.001). Treatment with tofacitinib also results in fewer cells in population IV compared to 





The second coordination point occurs after the IgH locus has been completely rearranged, as 
indicated by the intracellular expression of IgH protein. Based on Ki67 the cells re-enter a state 
of proliferation as they pass through this checkpoint, expanding the pool of pre-B cells, which 
have productively formed an IgH (Figure 4-12a, blue arrow) [90]. Interestingly, just preceding 
this pre-B cell expansion, there is a discrete spike in cell death as indicated by a surge in single 
cells with higher cPARP (Figure 4-12a, yellow line), consistent with cells that could not form a 
productive IgH rearrangement and thus were unable to pass through this developmental 
checkpoint.  
In concert with expression of Vpre-B and λ5, the newly expressed IgH now composes a 
complete pre-B cell receptor (pre-BCR). Mapping cells following B cell receptor cross-linking 
onto Wanderlust demonstrates that precisely paralleling the surface expression of the IgH (IgHs), 
cells are able to induce massive phospholipase C (PLC) gamma 2 phosphorylation (Figure 4-12b, 
red) as compared to the basal state (Figure 4-12b, black). Thus, with the presence of pre-BCR on 
the surface of the cells, they have yet again re-wired their regulatory signaling and have now 
become responsive to receptor cross-linking (Figure 4-12b, ~0.4 on Wanderlust).  
4.2.12 ex vivo differentiation assay confirms pro-B cell checkpoint  
We sought to further confirm the requirement of these checkpoints by interrogating the earliest 
pro-B cell checkpoint, as identified here, using an ex vivo differentiation assay (Figure 4-12c). 
Base on the re-wired regulatory signaling across fractions II to V (Figure 4-10), we hypothesized 
that a blockade of IL-7 dependent activation of STAT5 would inhibit the progression of cells 
through the pro-B checkpoint, in turn reducing the number of cells transiting from fraction II 
through the IL-7-dependent fraction III to fraction IV and beyond. Lin- human bone marrow 





with kinase inhibitors on OP-9 stromal cell feeders for six weeks and then the relative 
proportions of fractions II through IV was assessed by flow cytometry.  
Both Ruxolitinib (JAK1/2 inhibitor) and Tofacitinib (JAK1/3 inhibitor) restricted progression of 
cells from population II through to Population IV (Figure 4-12d). Both JAK inhibitors 
significantly decreased the frequency of cells in fraction IV, relative to a DMSO control. At the 
same time, there was a significant accumulation of the cells in population II when incubated with 
JAK inhibitors. The P38 inhibitor, did not have a significant influence on the allocation of cells 
across the 3 fractions though it did promote significant, albeit compartment independent, cellular 
expansion.  
Altogether, these ex vivo culture assays demonstrated that while the cells are capable of 
differentiation, as predicted in our pro-B cell checkpoint model, to successfully complete their 
developmental progression they depend on JAK mediated signals. Thus, free from the constraints 
of conventional genetics (i.e., gene- or cell-specific deletion), timing of expression and 
regulation (as simultaneously measured by single cell mass cytometry and ordered by 
Wanderlust) can identify physiologically relevant checkpoints and provide mechanistic 






4.3 Materials and Methods 
4.3.1 Primary Human Marrow 
For mass cytometry analysis, fluorescence activated cell sorting (for qPCR), and ex vivo cell 
cultures, fresh whole human bone marrow (BM) was obtained from healthy donors from 
AllCells, Inc. (Emeryville, CA). Samples were Ficolled and processed as described in Bendall et 
al [12] and used fresh or cryopreserved. Cryopreserved cells were thawed in 90% RPMI with 
10% Fetal calf serum (FCS) (supplemented with 20 U/mL sodium heparin (Sigma) and 
0.025U/mL benzonase (Sigma),1X L-glutamine and 1X penicillin/streptomycin (Invitrogen). 
Fresh samples were re-suspended in 90% RPMI with 10% FCS. 
4.3.2 Lineage Depletion 
Where indicated, BM mononuclear cell (MNC) preparations were lineage depleted prior to cell 
culture or cytometric analysis. In all cases except for the ex vivo cell culture, the preparations 
were fixed with 1.6% formaldehyde for 10min (PFA; Electron Microscopy Sciences, Hatfield, 
PA) prior to depletion. Cells were then washed with staining media (CSM: PBS with 0.5% BSA, 
0.02% sodium azide). For depletion, cells were stained with biotin-conjugated antibodies for 30 
minutes at a concentration of 5 million cells per 100ul. Cells were washed with CSM twice then 
incubated with BD Streptavidin Particles Plus (BD Biosciences, San Jose, CA) at the 
manufacturer’s recommended concentration for 30 minutes at room temperature. Particle-labeled 
cells were resuspended in CSM to approximately 2-8x107 cells/ml and placed in a magnetic 
holder for seven minutes. The supernatant was transferred to a new tube and the beads/cells were 





depletion and supernatant recovery. This washing procedure was repeated 2 times. Cells from the 
supernatant were then concentrated by centrifugation at 250g for 5 minutes. 
4.3.3 Mass cytometry analysis 
BM-MNCs were first stained for viability using cisplatin. Cells were then rested for 30min at 
37°C and perturbed with various stimuli and inhibitors prior to analysis.  Following perturbation, 
cells were immediately fixed with 1.6% paraformaldehyde (PFA; Electron Microscopy Sciences, 
Hatfield, PA) for 10 minutes. Cells were then washed with CSM and Fc receptor block was 
performed using Human TruStain FcX (Biolegend) following manufacturer’s instructions. Cells 
were then stained for surface proteins at room temperature for 30min. Following staining, cells 
were washed twice with CSM and permeabilized with 4°C methanol for 10 minutes at 4°C. Cells 
were then washed twice with CSM and stained for intracellular proteins for 30 min at room 
temperature. Cells were washed with CSM and stained with 1 mL of 1:5000 of 2000x Ir DNA 
intercalator (DVS Sciences) diluted in PBS with 1.6% PFA for 20 minutes at room temperature 
up to overnight at 4°C. 
4.3.4 Mass cytometry panel 
The mass cytometry panel included the following markers: 
Marker 
name 
Brief description Ref 
Surface markers 
CD45 Pan-leukocyte marker [59] 
CD19 Pan-B-cell marker [59] 





IgD Immunoglobulin; marker of immature cells migrating out of the 
marrow 
[89] 
CD79b Part of the BCR [89] 
CD20 Mature B-cells marker [59] 
CD34 Stem cells marker and marker of precursor stages of various cell 
lineages 
[59] 
CD179a Vpre-B, part of the surrogate light chain [111] 
CD179b Lambda5, part of the surrogate light chain [111] 
CD72 Pan-B-cell marker [89] 
IgM BCR heavy chain [89] 
Kappa Light chain component [94] 
Lambda Light chain component [94] 
CD10 Precursor and early B-cells marker [59] 
CD49d Integrin involved in homing to the bone-marrow niche [112] 
CD24 Pan-B-cell marker [89] 
CD127 IL-7-R, involved in pro-B cell signaling [113] 
CD38 B-cell progenitor marker [114] 
CD40 Antigen-presenting cells marker [89] 
CD117 Precursor cells marker [59] 
HLA-DR Antigen-presenting cell surface receptor [114] 
Signaling markers 
pCreb Transcription factor involved in pre-BCR-mediated cell expansion [89] 





(IP3) that activate Erk 
pSrc Protein tyrosine kinase. Transmits the pre-BCR signal for cell 
expansion 
pAkt Phosphorylates Foxo1, a transcription factor for Rag1/2, leading to 
its degradation after pro-B and pre-B cell rearrangements 
pSyk Protein kinase. Activates pPLCg2 
pErk1/2 Extracellular signal-related kinase. Phosphorylates several 
transcriptional regulatory proteins involved in B-cell development 
pP38 Mitogen-activated protein kinase. Phosphorylates various 
transcription factors involved in B-cell development 
pStat5 Part of the IL-7 signaling pathway involved in pro-B cell 
development 
[98] 
Cell cycle markers 
cParp An indicator of programmed cell death [115] 
Ki67 Proliferation marker [116] 
Genomic rearrangement enzymes 
Rag1 Activates V(D)J rearrangement along with Rag2 [94] 
TdT DNA polymerase that adds nucleotides to the 3’ terminus of DNA [59] 
Table 4-1. List of markers used in mass cytometry 
The table lists all of the markers used in the mass cytometry panel, organized by their function (cell surface, 
signaling, cell cycle and genomic rearrangement). 
4.3.5 Mass cytometry analysis data pre-processing 
Prior to CyTOF analysis cells were washed once with CSM and then twice with ddH2O. To 





standards. Cell events were acquired at approximately 500 events per second on a CyTOF I 
(DVS Sciences). Each patient sample was individually normalized to the internal bead standards 
prior to analysis. Mass cytometry data cleaning was performed at www.cytobank.org.  To 
remove dead cells, debris, and non-B cell types data was gated based on cell length and DNA 
content as described in Bendall et al. [12] and for cisplatin negativity. Remaining cells were 
filtered for high expression levels of CD3 (T cells), CD33 (myeloid), CD11c (dendritic cells), 
CD16 (NK cells), CD235 (erythrocytes) and CD61 (platelets) prior to Wanderlust analysis or 
manual population gating. 
4.3.6 Wanderlust parameters 
The following parameters were used in all Wanderlust runs unless otherwise stated. As 
demonstrated in the results section, each of these values, including the early cell selection, can be 




s The early cell that is used in calculating the initial orientation trajectory 
Synthetic data: (1, 1, 1), the point from which the simulated trajectory 
originates. 
Mass cytometry healthy bone marrow data: the cell with max(CD34-IgM) * 
k Number of neighbors of each node in k-nearest neighbors graph. 30 
l Number of neighbors selected for each node in each l-k-nearest 
neighbors graph in the ensemble 
5 





nl Number of landmarks 20 
* This criterion was set in order to choose a stem cell (CD34+) while avoiding a possible stem 
cell-mature cell doublet (which would be CD34+IgM+, a non-physiological condition). 
Table 4-2. Default Wanderlust parameters 
A list of the Wanderlust parameters, explanation of each parameter and the default parameter used in all 
experiments (unless otherwise stated). 
All ten dimensions were used as input for the synthetic data. For the B-lineage data, the 
following surface markers were used: CD45, CD19, CD22, IgD, CD79b, CD20, CD34, CD179a, 
CD72, intracellular and surface IgM, Kappa, CD10, Lambda, CD179b, CD49d, CD24, CD127, 
CD38, CD40, CD117, HLADR. 
The output trajectory was normalized using the following equation: 
      
    
      
 
where w is the output trajectory and pi is the ith percentile of the output trajectory. By using the 
5th/95th percentiles we avoid cases where a distant outlier cells skews the rest of the trajectory. 
4.3.7 Cosine distance 
Euclidean distance was used in Wanderlust runs on the synthetic data. However, marker 
intensities in data acquired via mass cytometry are given in arbitrary units, that is, the scaling of 
each channel is independent of the other channels. Therefore, the proportions between markers 
are arbitrary as well (figure 4-13a). As a result, measuring cell-to-cell distances using a norm 
(such as the L
1
 norm, cityblock distance, or the L
2
 norm, Euclidean distance) could lead to 
different distance distributions depending on the specific scale (figure 4-13b, top). Additionally, 
due to the varying scales, markers become weighed by the dynamic range of their acquisition 





To address this pro-Blem, we provide Wanderlust with the cosine distance, which is defined for 
a pair of cells (s, t) as: 
         
     
√            
  
 
where xi is the vector representing cell i. d(s,t) is equal to 1-cos(θ), where θ is the angle between xs 
and xt in the high-dimensional space, hence the name cosine distance. Cosine distances are scale-
independent and their distance distribution remains relatively constant after scaling changes 
(figure 4-13b, bottom). 
 





(a) Left: In this toy example two separate clusters have been randomly sampled from a two-dimensional 
Gaussian with center (0.2, 1) (green) or (1, 0.2) (blue). The two dimensions have equal scales. Right: The X-
axis has been stretched by a factor of three, shifting the blue cluster to the right. (b) Top: The L2 norm 
(Euclidean distance) distribution in the equal scale data (blue) and the stretch X-axis data (green). We see that 
intra-cluster distances remain the same, while inter-cluster distances are shifted by the same factor as the 
stretching of the X-axis. Bottom: The cosine distance distribution in each dataset. Intra-cluster distances still 
remain the same and the inter-cluster distances are much closer to each other.  
4.3.8 Calculation of marker trace across the trajectory 
We divided the Wanderlust trajectory into 100 equidistant windows. The width of each window 
was equal to 8% of the total trajectory width (each window included all cells whose trajectory 
score was +/-0.04 of the window’s center). For each marker, the marker’s trace is defined as the 
marker median in each window, normalized to the 0-1 range by subtracting the minimum and 
dividing by the maximum marker value. 
4.3.9 Cross-correlation of trajectories across individuals 
Cell subtype proportions across the developmental trajectory might change between individuals 
due to many factors, such as genetics or recent exposure to pathogens. As a result regions of the 
Wanderlust trajectory might become shorter or longer, depending on proportions between cell 
subtypes (figure 4-14a). In order to synchronize the trajectory across individuals, we calculated 
the cross-correlation between each sample and an arbitrarily chosen base sample. The cross-
correlation was calculated as the mean of all marker cross-correlations. Then, the trajectory score 







Figure 4-14. Cross-correlation allows comparison of trajectories between samples. 
Wanderlust has been applied to two healthy bone marrow samples, in blue and green, respectively. (a) The 
TdT trace over the trajectory in each sample, before cross-correlation shift. The green sample has more TdT
+
 
cells, leading to a wider TdT
+
 region in the trajectory. Pearson’s ρ=0.8. (b) After shifting by the maximal 
cross-correlation between the two samples, the TdT
+
 section has a higher overlap. Pearson’s ρ=0.89. 
4.4 Discussion 
Wanderlust detects the trajectory, the underlying temporal element, in a system. The algorithm is 
resilient to noise, consistent between samples and scalable to up to tens of millions of points. It 
extracts the trajectory from a snapshot of the system rather than from time-series data and only 
requires an approximate starting point as prior information. The Wanderlust trajectory is 
continuous; in addition to mapping stable cell states, it also provides information about the 
transitions between them. The combination of these characteristics makes Wanderlust ideal for 
the exploration of any system that undergoes a developmental process. 
We have shown that Wanderlust finds the developmental trajectory of human B-cell 
development in the bone marrow. The trajectory is consistent with our current understanding of 
this process. Furthermore, Wanderlust provides a quantitative, high-resolution ordering of 





and relevance was previously unknown. In addition to validating many observations from mice 
in human, Wanderlust unveils a hitherto inaccessible systems-level landscape of early B-cell 
development: the coordination between the many mechanisms that regulate this process, 
including surface marker expression, signaling, proliferation and apoptosis. The Wanderlust 
trajectory represents the most comprehensive analysis of the human system to date, unifying all 
relevant cellular features and regulatory behaviors of early B-cell development in the human, and 
lays a roadmap for its further exploration. 
The continuous approach diverges from existing models of development. The trajectory captures 
expression as trends: markers rise and fall in patterns that correspond to the cell’s behavior. 
Instead of examining cell stages, we see transitions that cannot be classified under a discrete 
partitioning. This perspective can also be extended to the relationships between markers. We can 
utilize the trajectory in order to examine regulation in a holistic manner, as the coordination of 
and interaction between the different regulatory mechanisms. By providing a unified framework, 
the trajectory highlights transition periods when the cell is undergoing a regulatory or genetic 
transformation. 
4.4.1 Detection of more complicated trajectory structures 
Branching is an exciting future direction for Wanderlust. The current version of the algorithm 
assumes that the developmental process is composed of a series of consecutive stages that lead to 
a single fate. A more sophisticated model could aid in the exploration of systems that involve 
branching at different stages of the development process and lead to multiple fates. One 
approach for the design of such a model will be to follow chains of cells that break the linearity 
assumption. The model will start with multiple “naïve” Wanderlust runs from different points 





equal C. This final inequality signifies a potential branching point between the triplet’s members. 
Multiple such relationships will pinpoint the branching point’s position. 
In the context of early B-cell development, such an extension might be able to identify the 
development of B-1 cells, which are B lymphocytes that are involved in the humoral immune 
response [113, 117]. Most of the body’s population of B-1 cells originates from fetal precursors 
that undergo constant proliferation; however, pre-B cells could develop into B-1 cells with very 
low efficiency [118, 119]. The developmental process of B-1 cells in adults and the purpose of 
this process are still unclear. A Wanderlust algorithm that incorporates branching should be able 
to detect such a tiny population. Additional applications for a branching Wanderlust include the 
development of activated B cells in the germinal center and their branching into different 
antibody isotypes, the complete immune system, or the progression of other types of stem cells. 
4.4.2 Application of the developmental trajectory to disease 
The intimate connection between the healthy and the abnormal is exemplified by cancer, a 
condition which originates from a deviant developmental process. As such, mapping the normal 
immune system lays the foundation for understanding the disease. The trajectory lead to 
identification of coordination points where the cell transitions from one developmental stage to 
another, coupled to the regulatory signaling involved in this process. This suggests specific 
periods of risk for transforming to malignancy, should regulatory protections fail. The next step 
would be to harness this information, for example, in the experimental dissection of cancer by 
interfering with the key players identified through Wanderlust in critical moments through 
development. The newly-gained understanding of normal B-cell development will be 





A branching version of Wanderlust could be applied directly to single-cell measurements of 
malignant samples. The algorithm will detect the disease’s developmental process, which will in 
turn be overlaid on top of the healthy trajectory using methods similar to those we utilized in 
comparing normal samples. By applying the algorithm to cancer in its earliest stages, for 
example a sample taken from a mouse, we should be able to identify whether the cancer 
originated from a specific early cell stage, which regulatory mechanisms have been abolished by 
the disease and which are still operational. Alternatively, the Wanderlust trajectory of a more 
advanced form of the disease will shed new light on its corrupted developmental process, how its 
cells proliferate and whether and how they die. Answering these questions would assist in 
directing future research toward the most promising treatments. 
4.4.3 A universe of development 
Wanderlust requires very few pieces of information in order to detect the trajectory: single-cell 
measurements and a starting point. While we examined the highly-studied system of B-cell 
development, the algorithm could be applied to less-explored systems such as the development 
of induced-pluripotent stem cells (iPSCs). The analysis in that context will proceed along similar 
steps to those taken with B-cell development: a population of iPSCs will be grown and assayed 
via a mass cytometer, possibly at different time points. This system has the distinct advantage 
that the selection of the starting cell is trivial. The Wanderlust trajectory will lead to new insights 
on how iPSCs differentiate into the various lineages and how their development differs from 
regular stem cells. A more exciting possibility is detecting the trajectory a somatic cell undergoes 






Two features of the algorithm are advantageous in the context of unfamiliar developmental 
systems. First, we supplied Wanderlust with an early starting cell (a CD34+ CD38- stem cell). 
However, as seen in figure 4-5, the algorithm could instead begin from a late cell and map the 
trajectory from a known finale back to its beginning. This variation is relevant in the context of 
non-hematopoietic development, where the stem cells are not known but where the mature cells 
are both plentiful and easily identified, such as in mesenchymal development. Two, overlaying 
known information over the combination of multiple marker traces pinpoints the position of de 
novo transition states. As in the present work, validation of these states could be done 
experimentally. The combination of trajectory detection from a mature cell and demarcation of 
transition states will be pivotal in exploring a new system. 
Finally, Wanderlust could be utilized outside the realms of biology, in any situation in which we 
are exploring a dynamic system but are unable to acquire time-series data. The algorithm is a 
hypothesis-generation method with broad applications. 
One of the biggest challenges in research is deciding where to look. In order to ask the right 
questions, we need some initial understanding of the structure of the pro-Blem being examined. 
The existence of a developmental process provides us with a powerful scaffold to that end. Based 
on this insight, the trajectory captures the central dynamic in the data: Wanderlust provides the 






Chapter 5 Conclusions 
The advent of high-dimensional, single-cell methods marks a new era in the life sciences. Flow 
cytometry and related microscopy techniques have taught us to appreciate the roles of 
heterogeneity and stochasticity, two concepts that were the realm of theory until a decade ago. 
Recent advances push the number of dimensions ever higher by abandoning the limited 
fluorescence-based protocols in favor of novel methods. Mass cytometry, single-cell RNA 
qualification, and other technologies can assay up to a hundred parameters in each cell, opening 
a window into mechanisms that were previously inaccessible. However, new technologies lead to 
new challenges as current statistical tools cannot handle the tsunami of new data being 
generated. In order to reach the full potential of the latest breakthrough technologies, we need to 
adopt a fresh outlook on how to process, analyze and integrate “big” biological data. 
Here we presented two new computational methods for the exploration of high-dimensional data. 
The first, viSNE, is a dimensionality reduction algorithm that maps the data into two dimensions. 
By projecting complex relationships into a familiar scatter plot, viSNE provides a visualization 
of information that would not be immediately accessible otherwise. The viSNE map highlights 
the separation between different cell subtypes (both healthy and malignant), draws the 
progression of cancer from diagnosis to relapse and accentuates a tiny cancer population in a 
minimal residual disease setting. The second algorithm, Wanderlust, detects the developmental 
ordering (the trajectory) of cells without requiring any time-series experiments. We used 
Wanderlust to identify the progression of healthy B cell development. It reveals the coordination 





coordination between signaling, proliferation and apoptosis in the pro B-cell checkpoint). These 
two algorithms translate nearly impervious data into intuitive constructs. 
Taken together, viSNE and Wanderlust offer a completely new outlook on biological data. 
Classic experimentation techniques follow the production, regulation, function and degradation 
of a handful of molecules at a time. Genomic-based techniques, such as microarrays and 
sequencing, scale this philosophy into a large set of assayed molecules. However, they still 
examine individual molecules, or, at most, clusters or modules of molecules. The work presented 
here is a leap toward a true systematic view that takes the entirety of information and synthesizes 
it into a single coherent picture. These two algorithms incorporate all of the parameters examined 
into a single profile (with viSNE) or trajectory (in the case of Wanderlust). The discussion no 
longer revolves around a single protein or even a group of genes, but rather around their 
combination, and how this combination changes after perturbation by a treatment or by disease. 
Furthermore, since viSNE and Wanderlust preserve the single-cell resolution, we can use their 
low-dimensional representation in the design of validation experiments using well-established, 
classic approaches. Biology did not evolve one molecule at a time. To reveal its full potential and 
get a comprehensive understanding of life, we must follow this holistic philosophy. 
Technology is advancing in a staggering pace: we are constantly breaking the boundaries of what 
is possible and measure more parameters in higher resolutions than ever. This trend will only 
accelerate as time goes by. We have shown that viSNE and Wanderlust are robust in the 
algorithmic sense; however, maybe more importantly, they are also robust to the advent of our 
technology. Both algorithms are theoretically capable of processing tens of thousands of 
dimensions over millions of cells in reasonable computational times. As biology enters the 





ignores it will become obsolete, along with whatever instrumentation existed at the time of its 
conception. The design of viSNE and Wanderlust guarantees that they will stay in the forefront 
for years to come. 
The life sciences are undergoing a paradigm shift. When our starting point was confined by the 
available technology we were prone to lock into accepted dogma. However, we are entering a 
new era, where entire biological systems can be profiled and visualized using high-dimensional, 
single-cell technologies. The current work is a beginning, a proof of concept for exploring a 
small subset of what is possible. It leads to many further questions: How is the complete 
hematopoietic developmental process regulated? What is the role of coordination points in the 
emergence of other cell types? How are these processes perturbed by cancer and by immune 
deficiencies? Furthermore, we should not restrict ourselves to the immune system. Every organ 
in our body is a microcosm that can be charted using viSNE and whose trajectory detected with 
Wanderlust. In an ideal scenario, we will follow the greatest developmental process of all, the 
growth of a fetus and the differentiation of all of the many subsystems in our bodies. viSNE and 
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